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Abstract 
Purpose 
To evaluate the impact of a 12 week hospital-based phase III cardiac rehabilitation 
(CR) programme on long-term aerobic fitness and cardiovascular health two years 
after completion. 
Method                                                                                                                     
Nineteen male and five female participants (mean age 65 years + 2 years) who had 
completed the CR programme, were randomly recruited to the study. 15 (63%) 
participants had a diagnosis of MI, 4 (17%) had undergone PCI and 5 (21%) had 
undergone CABG. The study was a repeated measures design. Participants 
performed three sub-maximal exercise tests (up to 75% HRmax and/or RPE 12/13) on 
a cycle ergometer to assess aerobic fitness (determined by work rate in watts and 
METs achieved) at baseline, end of CR and at two year follow-up. Secondary 
measures for cardiovascular health profile (including body anthropometrics, HADS 
score) were also examined. A one-way (Repeated Measures) ANOVA and the 
Friedman test examined differences at baseline, end of the programme and at two 
year follow-up.  
Results                                                                                                            
Compared to baseline aerobic fitness improved significantly at the end of CR (p = 
0.0005) and at two years (p=0.0005). At two years there was no significant difference 
in work-rate (p=0.41) or METs achieved (p=0.63) compared to levels at the end of 
CR, indicating that participants maintained their aerobic fitness. The mean work-rate 
achieved by participants was 56.9 (+4.0) watts at baseline, 78.8 (+5.5) watts at the 
end of CR, and 76.8 (+5.2) watts at two years. Median METs achieved were 4.3 
METs (IQR = 0.9) at baseline, 5.2 METs (IQR = 1.4) at the end of CR and 5.2 METs 
(IQR = 1.7) at two years. 
Conclusions                                                                                                                             
A 12 week CR programme can lead to positive health behaviours, an improvement in 
participant’s aerobic fitness and aspects of their cardiovascular health profile, which 
is maintained two years following completion.   
Key words:  Cardiac Rehabilitation, Exercise Capacity, Long-Term, Follow-up. 
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Chapter 1 
Introduction and Literature Review 
 
1.1 Cardiovascular disease and Cardiac Rehabilitation 
Cardiovascular disease (CVD) is the leading cause of death globally and in the 
United Kingdom (UK) (British Heart Foundation, 2009a; WHO, 2009). Premature 
mortality from CVD is up to six times greater amongst lower socioeconomic groups, 
but rates vary considerably within the UK geographically, socially and ethnically 
(Department of Health [DoH], 2008; O’Flaherty et al., 2009). CVD is a major 
economic burden costing the UK approximately £30 billion annually (Luengo-
Fernandez, Leal, Gray, Petersen & Raynor, 2006). This impact demands that 
initiatives to reduce CHD remain a government and National Health Service (NHS) 
priority (DoH, 2000).  
The cause of CVD is multi-factorial, comprising both non-modifiable (e.g. gender, 
age, genetic predisposition and ethnicity) and modifiable risk factors. The risk of a 
first myocardial infarction (MI) is related to the following modifiable risk factors: 
physical inactivity, tobacco use, elevated blood cholesterol, high blood pressure, 
obesity, type II diabetes, psychosocial factors and excess alcohol consumption 
(Yusuf et al., 2004). These modifiable CHD risk factors also contribute to other 
leading causes of death including an increased risk of stroke, cancer and lung 
diseases (Cobb, Brown & Davis, 2006). Furthermore, several risk factors are linked. 
One such example is reduced physical activity, which as well as independently 
increasing CHD risk, is associated with diabetes, hypertension, obesity and  
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dyslipidaemia, each further increases the risk of more advanced CHD (Pearson et 
al., 2002).  
Unhealthy dietary and lifestyle behaviours are the major causes of CHD (WHO, 
2003). A variety of factors may determine CVD risk in adults including: food 
production/availability, access to an environment which encourages PA and 
education (National Institute of Clinical Excellence [NICE], 2010). Lifetime risk of 
CVD is heavily influenced by diet and levels of physical activity (PA) since childhood 
(National Heart Forum, 2003).  
CR programmes aim to target a number of lifestyle behaviour changes which 
include: increasing levels of habitual physical activity, improving dietary behaviours, 
cessation of smoking (if applicable) and helping with patients with their mental well-
being following diagnosis of CHD/ a cardiac related event (Smith, Arthur, McKelvie & 
Kodis, 2004). Amongst these lifestyle changes a number of ‘health factors’ are also 
addressed as required, with each CR patient: aerobic fitness, cholesterol levels, 
obesity, elevated blood pressure, diabetes/impaired glucose tolerance and quality of 
life (QoL). Both pharmacological treatment and lifestyle modification appear to be of 
equal value in order to reduce the risk of further mortality and morbidity (Taylor et al., 
2004). Although, the most difficult challenge for cardiac patients remain that of 
motivation and adherence to a long-term healthy lifestyle (Cobb, Brown & Davis, 
2006), however, this is to a lesser extent than that of the general population 
(Gianuzzi et al., 2003). The government continue to emphasise the importance of a 
lifestyle approach in the management of secondary risk factors, particularly physical 
activity status (Department of Health, 2000; National Institute for Health and Clinical 
Excellence, 2006).  
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Several studies have demonstrated the effectiveness that a reduction of 
cardiovascular risk factors, and subsequent improvement in cardiovascular health 
profile, can have on decreasing the number of recurrent coronary events and 
mortality from cardiovascular disease in patients post MI or revascularisation 
(Haskell, et al., 1994; Lear, et al., 2006; Willich, et al., 2001). Therefore, full 
examination of the CR patients’ cardiovascular health profile is crucial in order to 
identify and treat, including lifestyle risk modification, so as to appropriately manage 
the patient with pre-existing CHD. However, despite public health strategies and 
campaigns the majority of patients with CHD (85% or more) have at least one 
modifiable risk factor, defined as: hypertension, cigarette smoking, diabetes or 
dyslipidaemia (Khot et al., 2003). 
It is useful to consider four phases of CR as each represents a different component 
of the patient’s journey of care: (1) inpatient care, (2) early post discharge period, (3) 
outpatient rehabilitation and (4) long-term maintenance (SIGN, 2002). 
The majority of CR programmes typically offer a combination of different 
interventions including exercise training, patient education and psychological 
support/intervention. A lack of single-component intervention trials makes it difficult 
to evaluate the efficacy of individual components. A comprehensive approach to CR 
employing educational interventions, psychological support and exercise appears to 
be the most beneficial to cardiac patients, with trials showing that psychological and 
educational interventions can reduce coronary heart disease risk factors, improve 
psychosocial wellbeing and patient knowledge and may reduce morbidity and 
mortality (Joliffe et al., 2001; Dusseldorp et al., 1999; Linden et al., 1996).  
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1.2 The Value of Aerobic Fitness as a measure of outcome  
Aerobic fitness is a clinical value which is obtained from exercise testing in order to 
evaluate an individuals’ aerobic exercise capacity (also known as exercise tolerance) 
(Noonan & Dean, 2000). A maximal exercise test is considered the “gold standard” 
for assessing maximal aerobic capacity (VO2 max). VO2 max is a product of cardiac 
output (CO) and arterio-venous oxygen difference (a-v O2 diff), i.e. the ability of the 
muscles to extract oxygen, at exhaustion. However, the assessment of VO2 max has 
its limitations, it typically requires additional monitoring (e.g. electrocardiograph 
machine), highly trained staff, it is labour intensive and usually requires high levels of 
motivation from the individual (Noonan & Dean, 2000).  
The majority of activities of daily living (ADL) do not require maximal effort but rather 
sub-maximal exertion and patients with cardiac disease are often unaccustomed to 
vigorous exercise and have numerous other co-morbidities (e.g. diabetes, asthma) 
as well as some musculoskeletal limitations. Furthermore, maximal testing is not 
always safe (i.e. it may be contraindicated in some patients) or impractical to carry 
out thus a sub-maximal test may be more appropriate.  For this reason, although 
sub-maximal testing involves significant error, it does provide useful information of a 
person’s functional capacity (FC) (Lauer, Froelicher, Williams & Kligfield, 2005).  
Aerobic fitness has been demonstrated to be of great importance with greater levels 
of aerobic fitness related to a reduced relative risk of premature death. Kavanagh et 
al. (2002) examined over 12,000 male patients with a coronary diagnosis who were 
referred for CR and assessed their maximal aerobic capacity. The results found that 
values of 4.3 to 6.3 METs (15-22 ml O2/kg per minute, p = <.0001) and greater than 
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6.3 METs (>22 ml O2/kg per minute, p = <.0001) led to a 38% and 61% reduction in 
the risk of cardiac related death over a median of 7.9 (range 4 to 29) years.  
 
Furthermore, the estimated 15 year prognosis improved considerably from the least 
fit group (average VO2 peak of 13 ml O2/kg per minute, 35% mortality) to the middle 
group (average VO2 peak of 18.6 ml O2/kg per minute, 19% mortality).  
Myers et al. (2002) confirmed the protective role of a higher aerobic fitness even in 
the presence of other risk factors such as hypertension, smoking and diabetes in 
healthy individuals and those with CVD. The study demonstrated that improvements 
in cardiovascular fitness over time led to a better prognosis with every one MET 
increase in treadmill performance associated with a 12 percent improvement in 
survival. The results suggest that the least fit individuals can achieve the greatest 
health benefits by increasing their levels of physical activity (Myers et al., 2002). It 
must be noted that the study’s findings are only applicable to men, further 
investigation is required to evaluate how women’s exercise capacity impacts on 
mortality, especially since evidence suggests exercise test results for females differ 
significantly to men (Shaw, Hachamovitch & Redberg, 2000). Furthermore, although 
common practice, the data on exercise capacity was estimated based on the speed 
and grade of the treadmill, however, directly measured exercise capacity (VO2 max) is 
thought to be both a more accurate and reproducible measure of aerobic fitness and 
predictor of further outcomes (Myers et al., 1998). 
Dunn et al. (1999) examined lifestyle physical activity versus a structured exercise 
programme in a randomised 24 month trial in previously sedentary healthy adults. 
The study found that both groups (lifestyle intervention group and structured exercise 
group) significantly increased their levels of physical activity at six months (p <.001),  
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with no significant difference in participants’ self-reported maintenance of activity 
(over 18 months), with changes in CVD risk factors (blood pressure, body weight, 
body fat percentage, lipids) being well maintained or improved over the follow up 
period. However, at the 24 month follow up there was a significant decline in aerobic 
fitness in both groups, with the most significant reduction observed in the structured 
exercise group (p <.001).  Although, at the 24 month follow up both groups had a 
similar level of aerobic fitness, which suggests that significant improvements in 
aerobic fitness, physical activity and CVD risk factors can be achieved without 
necessarily having to attend a fitness facility but by incorporating lifestyle physical 
activity. 
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1.3 Sub-Maximal testing as a measure of Aerobic Fitness in Cardiac 
Rehabilitation 
Patients with cardiac disease often present with a decreased FC and sub-maximal 
testing can provide a useful means of estimating or predicting the VO2 max (i.e. 
aerobic fitness level) of patients in a CR setting (Fleg et al., 2000).  When FC is 
estimated rather than measured directly it is often expressed in metabolic 
equivalents (METs) which is an indirect measure of oxygen uptake; 1 MET 
represents resting energy expenditure which is approximately 3.5 ml O2·kg-1·min-1 or 
millilitres of oxygen per kilogram of bodyweight, per minute (Fleg et al., 2000). 
Although METs is a common method used to quantify the energy cost and intensity 
of physical activity, studies suggest that the MET value of 3.5 ml O2/kg of 
bodyweight/minute substantially overestimates directly measured values by 30 to 
35% (Byrne, Hills, Hunter, Weinseir & Schutz, 2005). Savage, Toth & Ades (2007) 
suggest that even after adjusting for differences in technique and body composition, 
the well accepted value for one MET was overestimated by more than 23% in those 
with CHD. Presently, there is no single definition of how a MET should be measured 
and further evaluation is needed.  
Sub-maximal or predictive testing involves several assumptions: (1) steady-state 
heart rate (HR) is obtained for each exercise work rate, (2) a linear relationship 
exists between HR and work rate, (3) the maximal heart rate for a given age is 
uniform, and (4) mechanical efficiency (i.e. oxygen at a given work rate) is the same 
for everyone (ACSM, 2006). The selection of an appropriate sub-maximal exercise 
assessment is of crucial importance in many respects including patient safety and to 
enable the CR practitioner to provide accurate physical activity guidance. Sub-
maximal walking, step and cycle tests are commonly used to provide important 
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clinical information to the CR practitioner including; assessment of functional 
capacity, the outcome of interventions, aid in risk stratification for future cardiac 
events and to assist in appropriate exercise prescription and advice (Gulati & 
McBride, 2005).   
 
1.4 Impact of Cardiac Rehabilitation on Cardiovascular Health Profile  
Lear et al. (2006) conducted a randomised controlled trial to investigate the 
effectiveness that long-term modest risk factor and lifestyle intervention can have on 
individuals after a CR programme over four years. Risk factor and lifestyle 
counselling sessions were conducted at regular time points over the 4 year (48 
month) period by the case manager, with exercise capacity also assessed at six, 12, 
24 and 36 months. Recommendations to other health professionals were made as 
appropriate following each session (i.e. to the dietician, exercise specialist or study 
cardiologist with regards to medication changes). After completion of the CR 
programme 302 patients were recruited and randomised to the study. The Extensive 
Lifestyle Management Intervention (ELMI) trial resulted in a modest non-significant 
improvement in global risk of ischaemic heart disease in favour of the intervention 
group with respect to the Framingham risk score: -0.60 + 2.71 versus 0.01 + 2.51 (p 
= .081) for the intervention and usual care groups, respectively.  The authors 
acknowledge a limitation of the study is the use Framingham risk score as measure 
of global risk of ischaemic heart disease because it was designed to predict risk in 
primary prevention i.e. individuals without established CHD (Lear et al., 2006). 
Further, the Framingham risk score does not encapsulate changes in exercise 
capacity or body mass index (BMI), which are typically targeted in CR programmes 
(Bethell, Lewin & Dalal, 2009). 
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Gupta, Sanderson and Bittner (2007) examined which benefits achieved during CR 
were maintained one year following discharge and whether gender specific 
differences exist. Two hundred and forty-four patients returned for the evaluation at 
the one year follow up. The outcome measures were assessed at baseline, CR 
completion and at the one year follow up and included:  six-minute walk distance (6-
MWD), BMI, total cholesterol, low density lipoprotein cholesterol (LDL-C), high 
density lipoprotein cholesterol (HDL-C), triglycerides, self-reported physical activity, 
physical and mental component scores of the SF-36, depression and current 
smoking rates. At completion of CR significant improvements were observed in all 
the outcome measures except HDL-C and smoking (p = <.05). However, at the one 
year follow up visit there was a significant decline in 6-MWD, BMI, diet score and 
smoking rates in comparison to values at completion of CR, although HDL-C and 
physical component scores improved. LDL-C, triglycerides, depression score, self-
reported physical activity and mental component scores remained the same from 
completion of CR to one year.  Importantly, compared to baseline data, outcome 
measures at the one year follow up were significantly improved in all clinical, health 
status and behavioural measures expect for BMI, smoking status and triglycerides. 
Men who returned for the one year follow up evaluation were typically older, less 
obese, with lower total cholesterol and better diet scores compared to males who did 
not choose to return. Women were more likely to be white, have a longer 6-MWD, 
lower BMI and triglycerides and tended to self-report higher levels physical activity 
than those women who did not return.  Improvements in most outcome measures 
were similar amongst men and women, with women generally demonstrating a 
smaller increase in 6-MWD, but a significantly larger reduction in total cholesterol 
compared with men (p < .001, comparing baseline to CR completion) and greater  
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improvements in triglyceride levels and diet scores (p < .001, comparing baseline 
and one year follow up).  
Willich et al. (2001) reported similar findings in cardiac risk factor outcomes following 
completion of CR demonstrating that an adequate reduction in cardiac risk factors, 
and improvement in cardiovascular health profile achieved by many patients during 
in-hospital CR is not being maintained 12 months later. The prospective study, which 
examined 2441 patients following myocardial infarction (MI), coronary artery bypass 
graft (CABG) or Percutaneous coronary intervention (PCI) (from admission to, and 
discharge from CR and at three, six and 12 months later), demonstrated a significant 
decline in lipid control and a resumption of smoking between completion of CR to 
one year later. Furthermore, reports suggest that exercise adherence decreases and 
body weight and serum lipid levels increase as early as six months after CR has 
finished (Willich et al., 2001). An important observation in this study is the associated 
decline in the rate of prescription of cardiac medication and a high rate of recurrent 
clinical events: 886 patients (43% of all patients with complete follow up information) 
experienced at least one clinical event during the follow up, 69% of those occurred 
six months after CR discharge. A similar finding was observed by Boesch et al. 
(2005) with regards to lipid control, total cholesterol (p <.05), triglycerides (p <.05) 
and total cholesterol/HDL ratio (p <.01) which were all significantly higher at the two 
year follow up than compared to values on completion of CR. Aldana et al. (2003) 
found that although participants who received traditional CR demonstrated 
improvements in HDL-C, most other CHD risk factors remained the same or worse 
after six months following completion of the programme.  
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These findings are consistent with other studies on the progression of CHD through 
increased cardiovascular risk factors, the EUROASPIRE study observed 
approximately 50% of patients with coronary artery disease were not appropriately 
controlled for plasma cholesterol and high blood pressure, while 20% of patients did 
not have adequate management of smoking, BMI or diabetes (EUROASPIRE study 
group, 1997). The extent to which the results by Willich et al. (2001) can be 
generalised is limited since the CR policy in Germany incorporates only three to four 
weeks of in-hospital CR; this is quite different to that observed in UK programmes. 
The authors acknowledge that the 12 month follow up data was available for 85% of 
the total patient population and therefore the study may be associated with potential 
selection and information bias.  
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1.5 Maintenance of Aerobic fitness and Cardiac Rehabilitation  
A limited number of studies have reported on the benefits of CR beyond the point of 
discharge or completion from the formal programme with follow-up typically at one 
year (Appendix 1). Both observational and randomised controlled trials (RCT) have 
demonstrated mixed findings; some demonstrated maintained improvements in 
aerobic fitness through an increased exercise capacity, while others reported a 
return to baseline measures at follow-up.  
Historical evidence has suggested that the convalescent period following MI is 
associated with spontaneous improvements in functional aerobic capacity that may 
be because of the normal recovery processes that are unrelated to formal exercise 
training (e.g. DeBusk, Houston, Haskell, Fry & Parker, 1979). Dressendorfer et al. 
(1995) performed a randomised controlled trial examining 50, low risk, male patients 
recovering from acute MI during a five week ‘early’ CR programme. Patients were 
randomly assigned to four groups: one was a control group who were restricted to 
‘very light’ (<50% VO2 max) physical activity at home, the other three groups 
performed structured aerobic exercise at a moderate intensity (approximately 70% 
VO2 max), either once, twice or three times weekly at a hospital. The study 
demonstrated that only the patients in the training group who performed structured 
exercise showed significant improvements in VO2 max at follow-up when assessed on 
a treadmill. It is likely the differences in exercise training, the time of enrolment 
following MI or other cardiac diagnosis, the differences in the patient population and 
the impact of counselling may all influence the extent to which CR improves aerobic 
fitness and individuals’ cardiovascular health profile.
13 
 
Smith, Arthur, McKelvie & Kodis (2004) examined 222 CABG patients randomised to 
either six months of supervised hospital versus monitored home-based CR. At 
discharge from the CR patients were advised to continue to exercise a minimum of 
five times weekly at their prescribed target heart rate with patients also given an 
exercise log. The study demonstrated that exercise capacity (measured by peak 
oxygen uptake or VO2 peak), significantly declined in the ‘hospital’ group from 1616 + 
455 ml/min at 6 months to 1535 + 426 ml/min at the 12 month follow-up (p = 0.002). 
However, the ‘home’ group maintained peak VO2 between CR discharge and the 12 
month follow up (1567 + 430 ml/min versus 1565 + 437 ml/min), with the peak METs 
slightly declining in the ‘hospital group at the follow-up (p = 0.005). Importantly, the 
authors observed that both hospital and home groups maintained a significantly 
higher peak VO2, peak METs and peak work rate (p = <0.0001) than at baseline 
(entry to the CR programme). Of note, the study demonstrated that both groups 
(‘Home’ and ‘Hospital’) had significantly higher levels of habitual physical activity 
compared to the population norms for healthy adults with a mean age of 67 years 
(ACSM, 2006).  The finding that both groups maintained significantly higher levels of 
aerobic fitness after 12 months of non-intervention than baseline is supported with 
previous evidence by Dugmore et al. (1999) which also demonstrated improvements 
in cardio-respiratory fitness, psychological status and vocational status over a five 
year period following a 12 month CR programme.  
In contrast, Stalhe, Mattsson, Ryden, Unden & Nordlander (1999) found that in 
patients post coronary event (aged 65 years or more), although notable initial 
improvements in aerobic fitness were observed and remained above baseline levels 
at the 12 month follow up, the participants’ exercise capacity had actually declined 
considerably to almost baseline levels.  This suggests continued structured, 
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supervised training may be necessary in order to maintain achieved effects in this 
age population.   
Age and location of CR exercise may be an important factor when considering which 
individuals may benefit the most, not just in terms of maintaining and improving 
aerobic fitness but with regards to sustaining physical activity levels long-term 
following completion of CR. A randomised trial by Marchionni et al. (2003) 
demonstrated that CR post myocardial infarction (MI) enhances exercise tolerance in 
patients of all ages, with total work capacity (measured in kilograms per minute) 
consistently improving to a greater extent in middle-aged (45-65 years) and old 
patients (66-75 years) than in very old patients (> 75 years, traditionally excluded 
from CR trials). As observed in previous trials such (e.g. Smith, Arthur, McKelvie & 
Kodis, 2004) most of the initial improvements in exercise capacity with the ‘Hospital’ 
CR group was lost over the 12 month follow-up. By comparison the ‘Home’ group 
better preserved initial improvements in exercise capacity after 12 months following 
completion of CR suggesting that home based CR more effectively induces positive 
changes in lifestyle than hospital based CR in certain patients. Although the study 
specifies that certain patients were randomised to a ‘Home’ based CR group, the 
extent to which they can truly be defined as home-based is questionable since these 
patients initially participated in up to eight supervised sessions in the CR unit before 
being provided with a static bike and heart rate monitor for the training period.  
Arguably, this is not typical practice by National Health Service (NHS) CR 
programmes due to constraints to both resources and finances. Furthermore, unlike 
the hospital group, patients in the home group had a bike available to them following 
the end of the two month training period. This is may have had a considerable 
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impact on the both the participants’ long-term exercise tolerance and adherence to 
regular physical activity and exercise.    
While it is thought that continued exercise is required to sustain most benefits of CR, 
research demonstrates that just 30-60% of those who complete an outpatient CR 
programme are still physically active between three and six months later (Holmback, 
Sawe & Fagher, 1994; Moore, Roland, Pashkow & Blackburn, 1998). Boesch et al. 
(2005) demonstrated sustained improvements in maximal and sub-maximal exercise 
capacity following a one month residential CR programme at the two year follow-up. 
Peak watts and exercise duration were similar to the CR discharge exercise test, 
exercise capacity remained significantly higher compared to baseline measures at 
the start of the CR programme (p = <0.001). However, the study differed 
considerably in comparison to the standard CR programmes in the UK in that it was 
a residential programme; this is uncommon for CR programmes in the UK which are 
typically supervised, group, outpatient rehabilitation where patients are 
recommended, by the National Service Framework for Coronary Heart Disease, to 
attend twice weekly CR (DoH, 2000). Having the study participants living at the 
rehabilitation centre virtually ensured complete compliance with exercise, 
educational and dietary components of the programme (Boesch et al., 2005). The 
study was limited by the lack of a control group, arguably, those who attended the 
programme and agreed to return at the two year follow up may have been 
particularly motivated to make positive health/lifestyle changes following their cardiac 
event (Papageorgiou, Fotinakis, Tsitskari & Giasoglou, 2004) especially since it is 
more likely that volunteers will adhere to exercise programmes due to their 
expressed desire to participate (Daltroy, 1994). The exercise volume was also 
comparatively higher in this study than typically observed in UK CR (SIGN, 2002); 
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participants performed five times weekly, thirty minute cycling sessions and twice 
daily 45 minute walks. Notably, more than 54% of the participants in this study were 
retired, which perhaps made more time available for those individuals to engage in 
more recreational activity. The high standard deviation in mean energy expenditure 
at the two year point suggests a considerable variance in the patients’ long-term 
physical activity levels.  
Significant improvements in aerobic fitness were also observed by Arrigo, Brunner-
LaRocca, Lefkovits, Pfisterer & Hoffman (2008) one year following CR in both the 
intervention (INT) and usual care (UC) groups at baseline (completion of the CR 
programme) and at the one year follow-up (INT 153 + 52 watts at baseline versus 
163 + 49 watts at follow-up; UC – 144 + 52 at baseline versus 154 + 47 watts at 
follow up), p = <0.0005. Unlike other studies which have involved no intervention 
after CR completion (e.g. Smith et al., 2004) the intervention group participated in 
physician supervised exercise once every three months following completion of the 
formal programme. This contact following discharge from CR may have positively 
influenced adherence to independent exercise and led to positive health behaviours, 
since the participants may have been less likely to have wanted to ‘let the physician 
down’. The influence of physician’s on health behaviours is an area that requires 
further evaluation. 
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1.6 Rationale for this project 
Only a limited number of studies have reported on the benefits of CR beyond the 
point of discharge or completion from the formal programme. Both observational and 
randomised controlled trials (RCT) have demonstrated mixed findings with regards to 
improvements in aerobic fitness. While some studies have demonstrated sustained 
improvements in exercise capacity and improvements in cardiovascular risk factors 
following completion of CR (e.g. Boesch et al., 2005), other studies have actually 
shown a considerable decline in aerobic capacity after twelve months of non-
intervention following a hospital-based exercise programme (Smith et al., 2004). 
Protocols from other comparable studies have utilised additional interventions 
following discharge from the formal CR programme (e.g. Arrigo et al., 2008), 
therefore, evaluation of the impact that CR alone has on longer-term aerobic fitness 
and cardiovascular health is difficult and requires further investigation. 
Therefore, this proposed study aims to evaluate the impact of a twelve week 
hospital-based cardiac rehabilitation programme on long-term aerobic fitness and 
cardiovascular health profile two years after completion of the programme and add to 
the existing body of research. 
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1.7 Primary research objective 
To determine if aerobic fitness levels achieved prior to discharge from a Phase III 
(hospital-based) cardiac rehabilitation (CR) programme can be maintained two years 
after its completion, without further intervention.  
1.8 Secondary research objective 
The secondary aims are to examine changes in participants’ cardiovascular health 
profile including: blood lipids, blood pressure, smoking status, body anthropometrics 
(weight and waist circumference), physical activity levels, Hospital Anxiety and 
Depression score, hospital re-admission rate, quality of life and how these may 
impact on cardiovascular risk two years after completion of the programme. 
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1.9 STUDY HYPOTHESIS: 
1. Null hypothesis (H0): There will be no significant difference between aerobic 
capacity at the end of the cardiac rehabilitation programme and aerobic capacity at 
the two year follow-up. 
Alternate hypothesis (H1): There will be a significant difference between aerobic 
capacity at the end of the cardiac rehabilitation programme and aerobic capacity at 
the two year follow-up. 
2-6. Null hypotheses (H0): There will be no significant difference between total 
cholesterol/body weight/waist circumference/Rate pressure product/HAD score/ at 
the end of the cardiac rehabilitation programme and total cholesterol/body 
weight/waist circumference/Rate pressure product/HAD score at the two year follow-
up. 
Alternate hypotheses (H2-6): There will be a significant difference between 
secondary measures: total cholesterol (H2)/body weight (H3)/waist circumference 
(H4)/Rate pressure product (RPP) (H5) /HAD score at the end of the cardiac 
rehabilitation programme (H6) and secondary measures at the two year follow-up. 
7. Null hypotheses (H0):  There will be no significant relationship between the 
volume of physical activity (measured in MET-minutes per week using the IPAQ) and 
aerobic fitness (estimated METs 75% HRmax at the two year exercise test).  
Alternate hypotheses (H7-8):  There will be a significant relationship between the 
volume of physical activity (measured in MET-minutes per week using the IPAQ) and 
aerobic fitness (estimated METs75% HRmax at the two year exercise test). 
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8. Null hypotheses (H0):  There will be no significant relationship between waist 
circumference and total cholesterol measured at the two year follow-up. 
Alternate hypotheses (H8):  There will be a significant relationship between waist 
circumference and total cholesterol measured at the two year follow-up. 
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Chapter 2 
Methodology 
2.1 Participants 
24 participants who fulfilled the inclusion criteria (see section 2.2) were selected at 
random (using a random number generator) and invited and subsequently agreed to 
participate in the study (Appendix 2). The study sample consisted of 19 Males and 5 
females aged between 46-81 years (see Appendix 7 for recruitment and data 
collection procedure).  
300 patients enrolled onto the cardiac rehabilitation programme. From the total 
number of patients who initially enrolled on the programme a total of 100 patients 
completed the 12 week programme of cardiac rehabilitation (including exercise: once 
or twice weekly and health education (both formally and informally) at Good Hope 
Hospital between 2008 and 2009.  
Ethical approval for this study was acquired from the Birmingham East North & 
Solihull (BENS) Research Ethics Committee (Appendix 3) and Heart of England 
NHS Foundation Trust’s Research & Development Department (Appendix 4).  All 
participants had given their informed consent prior to participation in the study 
(Appendix 5). Further support for the study came from the Consultant Cardiologist 
and Cardiac Rehabilitation Coordinator at Good Hope Hospital (Appendix, 8 
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2.2 Inclusion criteria  
The participants must have completed the CR programme between 2008-2009, been 
diagnosed and successfully treated for a myocardial infarction (also known as heart 
attack) or angina and undergone successful coronary revascularisation, as a result 
of CHD (i.e. coronary artery bypass grafts or percutaneous coronary intervention, 
also known as coronary angioplasty with/without stenting). Participants also had to 
be English speaking to participate in the study.  
2.3 Exclusion criteria 
Proposed participants who have one or more contraindications to exercise testing, 
both absolute and relative, will be excluded from the proposed study, as suggested 
by the American College of Sports Medicine (ACSM, 2000) and Gibbons et al. 
(2002). See 2.3.1 and 2.3.2: 
2.3.1 Absolute contraindications to exercise testing 
•  A significant recent change in the resting electrocardiogram suggesting 
significant ischaemia, recent myocardial infarction (within 2 days) or other 
acute cardiac event 
• Unstable angina 
• Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic 
compromise 
• Symptomatic severe aortic stenosis 
• Uncontrolled symptomatic heart failure 
• Acute pulmonary embolus or pulmonary infarction 
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• Acute myocarditis or pericarditis  
• Suspected or known dissecting aneurysm  
• Acute systemic infection, accompanied by fever, body aches, or swollen 
lymph glands  
2.3.2 Relative contraindications to exercise testing 
• Left main coronary stenosis 
• Moderate stenotic valvular heart disease 
• Electrolyte abnormalities (e.g. hypokalemia, hypomagnesemia) 
• Severe arterial hypertension (i.e. systolic blood pressure of greater than 200 
mmHg and/or a diastolic blood pressure of >110 mmHg) at rest 
• Tachydysrhythmia or bradydysrhythmia (abnormally elevated resting heart 
rate >100bpm or abnormally low resting heart rate <60bpm) 
• Hypertrophic cardiomyopathy, musculoskeltal, or rheumatoid disorders that 
are exacerbated by exercise 
• High degree atrioventricular block 
• Ventricular aneurysm 
• Uncontrolled metabolic disease (diabetes-blood glucose > 14 mmol/L, 
thyrotoxicosis or myxedema) 
• Chronic infectious disease (e.g. mononucleosis, hepatitis, AIDS) 
• Mental or physical impairment leading to inability to exercise adequately 
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2.4 Study Design 
The same group of individuals who completed the CR programme (in 2008-2009) 
performed a sub-maximal exercise assessment (to measure aerobic fitness) on three 
occasions: at baseline (entry onto the CR programme), at the end of the programme 
(pre-discharge) and at the two year follow-up point. Therefore the nature of the study 
was a repeated measures design. Retrospective data from the hospital database 
and cardiac rehab patient notes was used, this included: exercise assessment data 
(Watts achieved at 75% HRmax, estimated METs achieved at 75% HRmax, blood 
pressures, rating of perceived exertion scores), blood lipids (cholesterol), body 
weight, waist circumference, Hospital and Anxiety and Depression (HAD) scores, 
smoking history and hospital readmission rates. To assess the participants’ 
functional aerobic capacity at the two year follow-up an experimental protocol was 
used. 
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2.5 Primary outcome measures: 
The outcome measures were taken at baseline (beginning of the CR exercise 
programme), at twelve weeks (prior to discharge from CR) and at the two year 
follow-up (testing point): 
a) Aerobic fitness was measured at the two year follow-up by a sub-maximal aerobic 
exercise cycle assessment (see section 2.8) to assess for changes in aerobic fitness 
over time. Aerobic fitness was measured by watts achieved at estimated 75% HRmax 
and Metabolic Equivalents (METs) attained at 75% HRmax on the exercise 
assessment at baseline, the end of CR and at the two year follow-up.  
2.6 Secondary outcome measures: 
b) Hospital Anxiety and Depression Scale (HADS). The HADS has been found to be 
a reliable instrument to detect states of anxiety and depression in hospital outpatient 
clinics (Zigmond & Snaith, 1983). Participants’ HADS score was measured at three 
time points: baseline, end of CR and two year follow-up. 
  
c) The International Physical Activity Questionnaire-short version (IPAQ-short), to be 
measured in median MET–minutes/week. Having undergone extensive reliability and 
validity testing across 12 countries the IPAQ has acceptable measurement 
properties suitable for use in a variety of settings as a measure of health-related 
physical activity (Hagstromer, Oja & Sjostrom, 2005). It is currently used by the 
National Audit of Cardiac Rehabilitation (NACR) as an evaluation tool and is utilised 
by a number of cardiac rehabilitation programmes to measure health-related physical 
activity levels nationally. This tool was used at the two year follow-up only.    
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d) The short-form 12 item Health survey (SF-12) is a tool used to measure general 
health/quality of life.  The SF-12 can assess the level of health/ill-health and degree 
of change overtime. The SF-12 also possesses high test-retest reliability in a 
cardiovascular setting (Bohannon, Maljanian & Landes, 2004; Jenkinson & Layte, 
1997). Quality of life using this tool will be measured at the two year follow-up only.  
 
e) Maintenance/change total blood cholesterol (measured in millimoles per litre or 
mmol/l) using existing data from the hospital database.  
f) Maintenance/change in pre-exercise blood pressure (measured in millimetres of 
mercury or mmHg). 
g) Maintenance/change in body weight measured in kilograms (kg).  
h) Maintenance/change in abdominal waist circumference measured in centimetres 
(cm) 
i) Smoking status (yes or no)  
j) Hospital readmission rates (for cardiac and non-cardiac reasons) since discharge 
from the cardiac rehabilitation programme using the hospital database.  
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2.7 Ethical Consideration  
Exercise with CHD brings risks to the cardiac rehabilitation patient. The researcher 
conducting the study was an experienced Exercise Physiologist within the Cardiac 
Rehabilitation Team at Good Hope Hospital who has training and competence in 
exercise testing and immediate life support.  Although a sub-maximal exercise 
assessment may be considered a safe procedure, risks and complications may 
occasionally arise during the test. These include abnormal blood pressure, fainting, 
irregular, fast or slow heart rhythms and rarely, heart attack, stroke or death 
(Fletcher et al., 2001). To minimise potential risks the participants were continually 
monitored prior to, during and following the exercise assessment with regards to 
heart rate and rhythm on the electrocardiograph (ECG) monitor, blood pressure and 
their Rating of Perceived Exertion. Furthermore, prior to assessment each participant 
was asked a series of health screening questions and was also required to fulfil the 
criteria for exercise testing (Appendix 6).  
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2.8 Procedure 
2.8.1 Exercise Assessment  
The protocol for this sub-maximal stationary cycle assessment (see Appendix 12 for 
cycle assessment data collection sheet) was adapted from Buckley, Holmes & Mapp 
(1999). 
Each participant was individually assessed in the cardiac rehabilitation department’s 
assessment room.  The researcher/exercise physiologist performed a pre-exercise 
interview to evaluate the participants' current health and cardiac status to ensure the 
patient was suitable and safe to exercise, i.e. they fulfilled the inclusion criteria (see 
pre-exercise test checklist, Appendix 6). The participant was informed verbally prior 
to commencing the exercise assessment as to the exact protocol of the test and the 
importance was stressed to the participant to immediately inform the exercise 
physiologist if they experienced any distressing/unusual symptoms, pain anywhere 
or anginal symptoms, however minor.  
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2.8.2 Equipment 
1. Cycle ergometer that accurately measures pedal work-rate in watts. 
2. Electrocardiograph (ECG) monitoring system   
3. Rating of Perceived Exertion scale (RPE, Borg, 1998) on a 6-20 graded scale 
4.  A sphygmomanometer (which is a manual blood pressure meter) 
5. Stethoscope 
6. Electronic weighing scales 
7. Tape measure (to measure abdominal waist circumference) 
8. Digital blood glucose monitor  
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2.8.3 Pre-exercise assessment protocol 
Each patient sat quietly for at least 5 minutes prior to the exercise test, before which 
the following pre-exercise test protocol was performed: 
• Seated resting blood pressure was measured (using a manual blood pressure 
meter known as a sphygmomanometer) and recorded. 
• A measurement of body weight (using electronic weighing scales) and waist 
circumference (by tape measure) was obtained.  
• Electrocardiograph (ECG) electrodes were carefully placed and secured on the 
participant to allow ECG monitoring to be performed throughout the assessment.  
A pre-exercise ECG trace was recorded and examined (to further assess for 
participant suitability to perform the test, i.e.no abnormal heart rhythms noted as 
described in the exclusion criteria) 
• If appropriate the participants’ blood glucose level was measured pre-exercise 
using a ‘finger prick’ glucose monitor. 
• The participant then sat on the static bike.  
• The seat height of the bike was adjusted so that the participants’ legs were 
almost completely extended when the pedals were at the lowest point.   
•  A manual blood pressure cuff was placed on the participant’ upper arm. 
• The RPE scale was described to the participant as per appropriate instructions.  
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2.8.4 Exercise cycle assessment protocol  
The exercise assessment was conducted by the cardiac rehabilitation exercise 
physiologist. 
• Each test started at 25 watts. For those participants who were felt to be quite unfit 
the exercise physiologist reduced the workload accordingly where necessary. 
• Each stage lasted 2-3 minutes for the cycle test. 
• The participant was encouraged to maintain a regular pedalling cadence which 
was set on an individual basis throughout the test, at 50 or 60 revolutions per 
minute (rpm). 
• Throughout the test participant’ symptoms/degree of discomfort (if any) was         
periodically checked. 
• A 3-lead telemetry ECG was continuously monitoring the participant’s heart 
rate/rhythm during the test as means of participant care and safety.  
• The work rate on the bike was gradually increased as appropriate during the test 
from (usually) 25 watts upwards, depending on the participants' heart rate, blood 
pressure, and RPE.   
• Exercise blood pressure was recorded every two minutes, and heart rate was 
recorded every minute  
• The participants were asked to give an RPE (according a 6-20 graded scale) 
each minute as a means of participant care, but this was only recorded every two 
minutes, at the end of each stage. 
• The test continued until the individual attained either approximately 75% of 
estimated maximal heart rate (65% heart rate reserve max) and/or an RPE of 11-
13, unless the participant became unwell (see stop test criteria, 2.8.5). 
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• At the end of the test the load on the cycle was reduced and the participant 
pedalled gently for at least two minutes recovery at a workload which was at least 
no more than they workload they started the test at. This was to allow for a 
reasonable recovery and normalisation of the participants’ heart rate, blood 
pressure and breathing rate before getting off the bike. 
 
•  If the exercise test is stopped for any of the reasons detailed on the ‘stop test 
criteria’ apart from the participants’ desire to stop or achieving a heart rate of 75% 
estimated maximum and/or an RPE of 11-13, which indicate the test should be 
stopped, the patient will be monitored in the assessment room until symptoms 
and/or ECG changes have completed resolved.  If any symptoms/signs were 
prolonged appropriate medical attention would be sort from cardiac rehabilitation 
staff and/or the cardiology team at the hospital.  
 
• Each participant was monitored for a minimum of 10 minutes post-exercise while 
seated during which time the participants’ heart rate, ECG and signs/symptoms 
were monitored.  
 
 
• Post-exercise blood pressure was measured at three minutes to ensure that it 
was returning to pre-exercise levels and also to avoid the risk of postural 
hypotension. 
 
• As appropriate, blood glucose was also measured to monitor patient safety and 
check for hypoglycaemia.  
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2.8.5 Stop test criteria for the exercise cycle assessment 
The individual participant attains either 75% of estimated maximal heart rate (65% 
heart rate reserve max) and/or an RPE of 11-13. 
Fatigue defined as an RPE score of > 15 ‘hard’), reaching a systolic blood pressure 
greater than/equal to 220mmHg and/or a diastolic blood pressure greater than/equal 
to 110mmHg (participant specific depending on other previous test results i.e. 
exercise tolerance test that demonstrated angina or cardiac ischaemia at a specific 
intensity).  
Symptoms such as: 1. acute chest pain/discomfort or other symptom suggestive of 
angina, 2. sudden pallor, 3. loss of coordination, 4. mental confusion, 5. extreme 
dyspnoea.  
Signs such as:  
1. ST segment depression (of more than 1mm) on the ECG  
2. T-wave inversion with any of the associated symptoms already mentioned  
3. Sustained ventricular tachycardia (dangerously elevated abnormal electrical heart 
rhythm) 
 4. A fall in systolic blood pressure by > 10 mmHg from baseline level despite an 
increase in workload, in the absence of other evidence of ischaemia (inadequate 
blood and oxygen supply) 
 5. The participants' desire to stop.  
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2.9 Data Analysis   
The following data were collected for statistical analysis at baseline (prior to 
commencement of the phase III exercise programme), at the end of CR (on 
completion of the programme) and at the two year follow-up: 
• Estimated METs at 75% HR max achieved on exercise testing 
• Watts achieved at 75% HR max on exercise testing 
• Waist circumference 
• Body weight  
• Pre-exercise BP’s 
• BP at 75% HRmax 
• RPP at peak exercise (a clinical measure of the heart's oxygen 
consumption/demand: which is multiple of heart rate and systolic blood 
pressure) 
• Hospital Anxiety and Depression Scale (HADS) score 
• Total blood cholesterol 
 All statistical data was analysed using PASW version 18 (SPSS) and the alpha 
values were set to p=0.05.  
The nature of the study was a repeated measures design using the same group of 
individuals. A parametric test, the One-way (repeated measures) Analysis of 
Variance (ANOVA) test was performed for the data that met the following 
assumptions: the data was of interval/ratio level, the same sample was being 
examined on at least three occasions and the data was normally distributed. A one-
way (repeated measures) ANOVA was performed to analyse the data for significant  
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differences between each assessment (at baseline, end of CR and two year follow-
up). As required, post hoc analysis was conducted using multiple T-tests (with 
Bonferroni adjustment) to see where the differences lay (Coakes & Steed, 2007).  
Data concerning the primary outcome measure, aerobic capacity, was analysed 
using data from each participant from the exercise test performed at baseline, at 
discharge and at the two year follow-up. The data was tested for significant 
differences in the watts achieved at 75% HRmax at each time point. Having met the 
assumption of normality (p>0.05) a one-way (repeated measures) ANOVA was 
performed to investigate for differences between data at the three aforementioned 
time points. To identify where significant differences lay post hoc analysis, with 
Bonferroni adjustment was performed to reduce the risk of committing a type I error 
(Williams & Wragg, 2004).   Aerobic capacity in watts was converted into estimated 
METs (achievedat 75% HRmax). This data failed the assumption of normality, 
therefore a non-parametric test; the Friedman test was performed to investigate 
differences between estimated METs achieved at 75% HRmax. Post hoc analysis was 
performed on the aerobic capacity data, and on other data where necessary, using 
multiple Wilcoxon tests to see where any significant differences were apparent (with 
Bonferroni adjustment) (Coakes & Steed, 2007). All descriptive statistics have been 
presented for all analyses.   
Metabolic Equivalents (METS) is an indirect measure of oxygen uptake (also termed 
aerobic capacity) used to assess an individual's functional capacity, 1 MET = 
approximately 3.5 millilitres of oxygen per kilogram of bodyweight per minute. 
Further data concerning secondary outcome measures including: total blood 
cholesterol, body weight and waist circumference, were analysed using the one-way 
(repeated measures) ANOVA was performed to analyse the data for significant  
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differences between time points (baseline, end of CR and two year follow-up), again 
where necessary, post hoc analysis was conducted using multiple T-tests (with 
Bonferroni adjustment) to see where the differences lay (Coakes & Steed, 2007). 
Health related quality of life (measured by the Hospital Anxiety and Depression 
Scale) was examined for significant differences in results using the Friedman test 
due to the data failing the assumption of normality. Post hoc analysis was again 
performed (with Bonferroni adjustment) to ascertain where the significant differences 
in results were apparent. To test for relationships Spearman's Rank Correlation 
Coefficient was performed to investigate for a relationship between total MET-
minutes per week and estimated METs at 75% HRmax at the two year follow-up.  A 
Pearson’s correlation was performed to test for a relationship between waist 
circumference and total blood cholesterol at the two year follow-up. 
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3. Results 
3.1 Subject characteristics 
24 participants, who fulfilled the study criteria (see section 2.2) after being randomly 
selected, completed the study. The participants were made up of 79% males (n=19), 
21% females (n=5). The mean age of all participants (n=24) was 65 years (+ 2 
years). There were no untoward events during sub-maximal exercise testing. Clinical 
and demographic characteristics are outlined in Table 1. Fifteen (63%) of the 
participants had a primary diagnosis of MI, 4 (17%) had undergone PCI, and 5 (21%) 
had undergone CABG. The new or recurring clinical events between CR discharge 
and the two year follow-up were: angina (n=3), repeat cardiac angiography or CABG 
surgery (n = 3), or non-cardiac procedure (n=1). The study participants’ raw data is 
presented in Appendix 11. 
Table 1. Participant Characteristics  
N 24 
Mean age + SD (year) 64.6 + 1.7 
Male, n (%) 19 (79) 
Female, n (%) 5 (21) 
MI, n (%) 15 (63) 
PCI, n (%) 4 (17) 
CABG, n (%) 5 (21) 
Previous smoking history, n (%) 16 (67) 
Currently smoking (at 2 year follow-up), n (%) 2 (8) 
Hospital Readmissions due to cardiac cause 
(post CR discharge), n (%) 
6 (25) 
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3.2 Aerobic Capacity  
Table 2. Exercise Test Responses (mean + SD), at baseline, after training, and 
after two years following cardiac rehabilitation (CR) completion 
 Baseline End of CR 2 year follow-up 
Watts achieved @  
75% HRmax  
56.9 (+4) 78.8 (+5.5)* 76.8 (+5.2)* 
RPP (HR*SBP/100) 160 (+6) 168 (+6) 172 (+7) 
Systolic BP (SBP), mmHg 
@ peak exercise (75% HR 
max) 
129 (+4) 133 (+4) 128 (+3) 
Diastolic BP (DBP), mmHg 
@ peak exercise (75% HR 
max) 
75 (+2) 74 (+2) 77 (+2) 
* P<0.017 vs. baseline assessment 
 
Table 3. METs achieved at approximately 75% HRmax as median values with the 
interquartile range (IQR), at baseline, the end of CR, and two years after CR 
completion 
 Baseline End of CR 2 year follow-up 
Estimated METs @ 75% 
HRmax, Median (IQR) 
4.3 (0.9) 5.2 (1.4)* 5.2 (1.7)* 
* P<0.017 vs. baseline assessment 
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3.2.1 Watts achieved at estimated 75% HRmax  
Participants with missing aerobic capacity data for one or more assessment were 
omitted from the analysis, n = 22 in this case.  
The data for participants’ aerobic capacity measured by watts at 75% HRmax, met the 
assumption of normality because p=>0.05 (Appendix 10), the Shapiro-Wilk statistic 
was consulted because the sample size was less than 100 (Coakes & Steed, 2007). 
A parametric test, the one-way repeated measures ANOVA (Table 4) was therefore 
performed due to the repeated measures design of the study.  The data met the 
assumption of sphericity (Appendix 10), p = >0.05, therefore, the ‘sphericity 
assumed’ statistic was used for the remainder of the analysis. 
 
Table 4. One-way (repeated measures) ANOVA to test for differences in watts 
at peak exercise at baseline, end of CR and two year follow-up. 
 
Trial F-ratio Sig. 
Sphericity Assumed 38.797 .000 
 
Observation of the results (Table 4) indicates there is a significant difference 
between the three trials (p = 0.0005). To find out where the differences lay post hoc 
analysis was performed by conducting three paired samples t-tests, with Bonferonni 
adjustment (p=0.05/3 = 0.017). This was done to reduce the risk of committing a 
type I error, since multiple tests were conducted on the same sample (Williams & 
Wragg, 2004). The new significance level was therefore set at p = 0.017 for the 
analysis of the aerobic capacity data (i.e. watts at 75% HRmax).  
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Table 5. Post hoc analysis using Paired samples t-test’s to examine for 
differences in watts at 75% HR max between assessments (baseline, the end of 
CR, at two year follow-up)  
 t Sig. (2-tailed) 
Pair 1: watts @ baseline  
& watts @ end of CR 
-7.39  .000 
Pair 2 :  watts @ baseline  
& watts @ 2 years 
-8.97 .000 
Pair 3 : watts @ end of CR 
& watts @ 2 years 
.84 .409 
 
The results (Table 5) of the post hoc analysis revealed that there was a significant 
difference between the participants’ watts achieved (at 75% HRmax) between both 
baseline and the end of CR (p=0.0005), and baseline and the two year follow-up 
assessment (p=0.0005). However, there was no significant difference in aerobic 
fitness (measured in watts) at the end of CR and the two year follow-up, p = 0.41. 
The mean watts achieved by participants at 75% HRmax (Table 2) were 56.9 (+4) 
watts at baseline, 78.8 (+5.5) watts at the end of CR, and 76.8 (+5.2) watts at the 
two year follow-up.  
 
3.2.2 METs attained at estimated 75% HRmax 
Participants with missing aerobic capacity data for one or more assessment were 
omitted from the analysis, n = 22 in this case. Estimated METs were calculated using 
published tables and calculations based on participants’ body weight, revolutions per 
minute and watts attained at approximately 75% HR max achieved on sub-maximal 
exercise testing (ACSM, 2006).The term METs achieved will be used to identify 
METs achieved at 75% HR max (i.e. sub-maximal exercise intensity). 
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The data concerning METs achieved (at 75% HRmax) at the three time points: 
baseline, CR discharge and two year follow-up were tested for normality (Appendix 
10). The data failed the assumption of normality and therefore a non-parametric test, 
the Friedman test was performed. The results in Table 6, p = 0.0005 (p= <0.05) 
indicate a significance difference in the participants’ METs at 75% HRmax achieved 
between baseline, end of CR and at the two year follow-up assessment. Post hoc 
analysis was performed by way of three Wilcoxon tests to ascertain where 
significant differences lay between the three testing points (at baseline and the end 
of CR, baseline and two year follow-up, and the end of CR and two year follow-up).  
The results of post hoc analysis is displayed in Table 7, Bonferroni adjustment set 
the new level of significance at 0.017 (p = 0.05 / 3), this was performed to reduce 
the risk of committing a type I error (Williams & Wragg, 2004).  
 
Table 6 – Friedman Test to analyse for significance differences in the METs at 
75% HRmax achieved at three time points: baseline, end of CR and at the two 
year follow-up 
N 22 
Chi2 29.301 
p .000 
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Table 7 – Results of post-hoc analysis using Wilcoxon tests to assess for 
significant differences between in aerobic capacity (METs at 75% HRmax) at 
three time points; baseline, end of CR and two year follow-up. 
 METs @ end of CR 
– 
METs @ baseline 
METs @ 2 year 
follow-up – 
METs @ baseline 
METs @ 2 year 
follow up – 
METs @ end of 
CR 
Z -4.020 -3.967 -.488 
p .000 .000 .626 
 
 
The results in Table 7 demonstrate that there is a significant difference in aerobic 
fitness as measured by METs at 75% HRmax, between the baseline assessment and 
discharge assessment (p=0.0005), and baseline assessment and the two year 
follow-up assessment (p=0.0005).  There was no significant difference between the 
METs at 75% HRmax achieved by patients at the end of CR and the two year follow-
up assessment (p=0.63). Therefore the null hypothesis (1) cannot be rejected.   
The median aerobic capacity is presented in (Table 3) at the end of CR was 5.2 
METs (IQR = 1.4) vs. 4.3 METs (IQR = 0.9) at baseline, the median aerobic capacity 
at the two year follow-up was 5.2 METs (IQR = 1.7) vs. 4.3 METs (IQR = 0.9) at 
baseline, at the two year follow-up: 5.2 METs (IQR = 1.7) vs. 5.2 METs (IQR = 1.4) 
at the end of CR.  
 
 
 
  
43 
 
3.3 Anthropometrics  
 
3.3.1 Abdominal Waist Circumference  
Participants with missing waist circumference data for one or more assessment were 
omitted from the analysis, n = 13 for the analysis of this data. 
Data was tested for normality (Appendix 10), p = >0.05 in the Shapiro-wilk statistic 
which indicated the data was normality distributed. Consequently, a one-way 
repeated measures ANOVA (Table 8) was performed. The data also met the 
assumption of sphericity (Appendix 10), and therefore the ‘Sphericity Assumed’ 
statistic was consulted to identify for significant results in the one-way ANOVA (Table 
6).   
 
Table 8. One-way Repeated Measures ANOVA to evaluate for differences in 
waist circumference at baseline, the end of CR and two year follow-up 
Trial F-ratio Sig. 
Sphericity Assumed  2.39 0.11 
 
The results from the one-way repeated measures ANOVA (Table 8) demonstrate 
that there is no significant difference in abdominal waist circumference between the 
three assessments (at baseline, end of CR and two year follow-up)  p = 0.11 (p = > 
0.05). The mean abdominal waist circumference was 100.3cm + 3.6cm at baseline, 
99.5cm + 3.3 cm at the end of CR and 102.5cm + 3.3cm at the two year follow-up.  
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3.3.2 Body weight 
Table 9. Anthropometrics (mean + SD), at baseline, after training, and after two 
years following cardiac rehabilitation (CR) 
 Baseline End of CR 2 year follow-up 
Weight (kg) (n=24) 81.2 + 2.6 81.3 + 2.5 82.1 + 2.2 
Waist Circumference (cm) 
(n=13) 
100.3 + 3.6 99.5 + 3.3 102.5 + 3.3 
 
The data concerning participants body weight met the assumption of normality      
(p= >0.05) and sphericity p = 0.16 (p = >0.05) (Appendix 10), therefore, a One-way 
Repeated Measures ANOVA was performed (Table 10). 
 
Table 10. One-Way Repeated Measures ANOVA examining for differences in 
participants’ bodyweight: at baseline, the end of CR and two year follow-up 
Trial F-ratio Sig. 
Sphericity Assumed .84 .44 
 
The results revealed no significant difference in body weight (Table 10) when 
measured at baseline, discharge and two year follow-up assessments (p=0.44).  
Therefore the null hypothesis (H0) cannot be rejected. The mean body weight at 
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baseline assessment was 81.2 (+ 2.6) kg, 81.3 (+ 2.5) kg at the end of CR, and 82.1 
(+ 2.2) kg at the two year follow-up, respectively. 
3.4 Total blood cholesterol 
Participants with missing total cholesterol data for one or more assessment were 
omitted from the analysis, n = 19 for the analysis of this data. The total cholesterol 
data (measured in mmol/l) was recorded at baseline, the end of CR and two year 
follow-up assessments. Because of the ratio level data and repeated measures 
study design a One-Way Repeated Measures ANOVA was performed because it 
met the assumptions of normality (p=>0.05) (Appendix 10). The data however failed 
the assumption of sphericity (p=<0.05) and therefore the ‘Greenhouse-Geisser’ 
statistic was used in the rest of the analysis (Appendix 10). 
 
Table 11. Blood Lipid Values (mean + SD) at baseline, after training and at the 
two year follow-up 
 Baseline End of CR 2 year follow-up 
Total Cholesterol (mmol/l), 
n=19 
4.4 + 0.2 4.0 + 0.2 4.1 + 0.2 
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Table 12. One-Way repeated measures ANOVA test to analyse for differences 
in total blood cholesterol measures (at baseline, end of CR and two year 
follow-up) 
Trial F-ratio Sig. 
Greenhouse-Geisser .75 .42 
 
Observation of the results (Table 12) revealed no significant difference between total 
cholesterol level at baseline, the end of CR or at the two year follow-up, p = 0.42 
(p>0.05). Therefore the null hypothesis (H0) cannot be rejected. The mean total 
cholesterol was 4.4 (+ 0.2) mmol/l at baseline, 4.0 (+ 0.2) mmol/l at the end of CR 
and 4.1 (+ 0.2) mmol/l at the two year follow-up, respectively.  
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3.5 Rate Pressure Product (RPP) 
Table 13. One-way (Repeated Measures) ANOVA to test for differences in Rate 
Pressure Product between exercise assessments (at baseline, end of CR, and 
two year follow-up).   
Trial F-ratio Sig. 
Sphericity Assumed 1.64 .21 
 
Data concerning participants RPP (HR x SBP at 75% HRmax / 100) met the statistical 
assumptions in order to perform a one-way (repeated measures) ANOVA (Appendix 
10) to investigate for differences in RPP between the three exercise assessments (at 
baseline, end of CR and two years following CR). Table 13 demonstrates that p=0.21 
(p>0.05) which is not significant. Therefore the null hypothesis cannot be rejected. 
The mean RPP at 75% HRmax at each assessment point was: 160 (+6) at baseline, 
168 (+6) at the end of CR, and 172 (+7) at the two year follow-up.    
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3.6 Health Related Quality of Life 
3.6.1 Assessment of Hospital Anxiety and Depression Scale (HADS) scores 
HADS score was assessed at baseline, end of CR and at the two year follow-up 
using a repeated measures design. Participants with missing data for one or more 
assessment were omitted from the analysis, n = 20 for the analysis of this data. 
The data failed the assumption of normality (Appendix 10) and the Friedman test 
was therefore performed to test for significant differences between the data at the 
three aforementioned time points.    
Table 14. Friedman Test to investigate for significant differences in HADS 
score at baseline, end of CR and two year follow-up 
N 20 
Chi2 21.73 
p .001 
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Table 15. Post hoc analysis using Wilcoxon tests to examine for differences 
between HADS score for Anxiety subscales and Depression subscales 
between three time points (baseline, CR discharge and at the two year follow-
up) 
 HAD 
Anxiety 
score @ 
end of CR 
– 
HAD 
Anxiety 
score @ 
baseline 
HAD 
Anxiety 
score @ 2 
year 
follow-up – 
HAD 
Anxiety 
score @ 
baseline 
HAD 
Anxiety 
score @ 2 
year 
follow up 
– 
HAD 
Anxiety 
score @ 
end of CR
HAD 
Depression 
score @ 
end of CR 
– 
Depression 
score @ 
baseline 
 
Depression 
score @ 2 
year F-up – 
Depression 
score @ 
baseline 
Depression 
score @ 2 
year F-up –
Depression 
score @ 
end of CR 
Z -2.09 -2.01 -.34 -2.60 -1.50 -1.75 
p .036 .044 .731 .009 .135 .081 
 
 
Table 16. HADS scores for Anxiety and Depression subscales as Median (and 
IQR) scores at Baseline, the End of CR and after Two Years  
 
 Baseline End of CR 2 year follow-up 
HADS score-Anxiety 4 (6) 2 (7) 2.5 (6) 
HADS score-Depression 2 (3) 1 (2)* 1 (4) 
*P=<0.017 vs. baseline assessment 
 
 
The results (Table 14) demonstrate that a significance difference existed in HADS 
score, p=0.001 (p<0.05) between measures taken at baseline, end of CR and at the 
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two year follow-up. Results of the post hoc analysis (Table 15) with Bonferonni 
adjustment (p = 0.05/3 = 0.017) revealed the following for the anxiety subscale: there 
was no significant difference between baseline and the assessment at the end of CR 
(p=0.04) or between baseline and the two year follow-up (p=0.04). There was also 
no significant difference in anxiety scores between the end of CR and the two year 
follow-up (p=0.73). With regards to the depression subscale, a significant difference, 
was observed between measures at baseline and the end of CR, p=0.009 (p<0.017). 
No significant difference was found between depression scores at baseline and at 
the two year follow-up (p=0.14) or between scores at the end of CR or the two year 
follow-up (p=0.08).  Therefore the null hypothesis cannot be rejected. Descriptive 
statistics are presented as median values (and interquartile range, IQR) in Table 16 
for the anxiety subscale: at baseline 4 (6), 2 (7) at the end of CR and 2.5 (6) two 
years after CR. Median scores for the HADS depression subscale were 2 (3) at 
baseline, 1 (2) at the end of CR, and 1 (4) two years after completion of CR. 
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3.6.2 Health related quality of life (HRQoL) assessed using the SF-12 
questionnaire   
 
Table 17. Health Related Quality of Life at the Two Year Follow-up assessed 
using the SF-12 questionnaire 
SF-12 Health questionnaire Mean (+SD) 
Physical component summary score 
(PCS) 
50.5 (+1.6) 
Mental component summary score 
(MCS) 
53.6 (+1.7) 
 
 
 
The results of participants HRQoL, measured using the SF-12 (Table 17), reveal 
both physical and mental component summary scores were above average levels at 
the two year follow-up, since scores are calibrated so that 50 is the average score or 
norm (Ware, Kosinski & Keller, 1996). 
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3.7 Independent Physical Activity  
 
 
Table 18. Total Physical Activity levels (in MET-minutes per week) and 
Participant Levels of Physical Activity measured by the IPAQ Two Years after 
CR 
 
 
Total MET-mins/week (mean + SD) 
 
3101 (2159) 
 
Level of Physical Activity 
 
Low, n (%) 3 (13) 
Moderate, n (%) 14 (58) 
High, n (%) 7 (29) 
 
 
Participants total MET minutes per week are demonstrated in Table 18, the majority 
of the participants’ (58%) participated in moderate intensity activities, either: three or 
more days of vigorous intensity activity lasting at least 20 minutes per day, five or 
more days of moderate intensity activity and/or walking of a minimum of 30 minutes 
daily, or a combination of walking, moderate or vigorous intensity activity on five or 
more days achieving at least 600 MET-minutes per week.     
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4. Discussion  
Whilst the benefits that CR have on patients following MI and revascularisation has 
been well documented, there is less documented studies that have evaluated the 
longer term benefits of CR beyond the point of discharge from the formal 
programme. Observational and randomised controlled trials have demonstrated 
mixed findings; with regards to sustained improvements in aerobic fitness in the 
longer time. The impact that a twelve week hospital-based CR programme can have 
on patients’ long-term aerobic fitness and cardiovascular health profile two years 
after completion of the programme, is an area which demands further investigation.   
The CR was typical of many programmes in England in that it was short, 12 weeks 
in the case of this study, where patients generally attended twice weekly exercise 
sessions, with the emphasis on cardiovascular conditioning. The CR also provided 
patients with both formal and informal education on their condition and how to 
manage it, along with dietary and lifestyle guidance and counselling.  
 
4.1 Discussion of results   
During the CR programme patients demonstrated typical benefits in aerobic 
exercise capacity, with an overall 38.5% increase in work rate (or 21.9 watts 
improvement from baseline fitness levels) (p < 0.017), with a 0.9 MET increase in 
estimated peak METs achieved between baseline and end of CR exercise tests (p < 
0.017). Although, overall the peak work rate was slightly reduced at the two year 
follow assessment, participants’ still demonstrated both a significantly higher work 
rate (with a 35% improvement from baseline levels) and aerobic capacity compared 
to baseline levels.  The salient finding was that the gains achieved in exercise 
capacity after completion of the CR programme were maintained two years following 
completion of the programme (Table 2), with watts and METs achieved at 75% 
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HRmax at the end of CR, both similar at the two year follow-up (p > 0.05). 
Consequently the null hypothesis cannot be rejected. There was no significant 
difference between aerobic capacity at the end of the CR programme and aerobic 
capacity at the two year follow-up.   
 
4.2 Discussion in relation to previous studies  
The current study’s finding that participants’ aerobic fitness remained significantly 
above baseline (entry to the CR programme) after two years following CR is 
consistent with evidence from other studies including, Smith et al. (2004), who 
demonstrated that the ‘hospital group’ maintained improvements in exercise 
capacity at the one year follow-up in peak VO2, peak METs and peak work-rate 
above baseline levels. Dugmore et al. (1999) reported improvements in cardio-
respiratory fitness, psychological and vocational status, which was maintained from 
one to five years following discharge from CR following 12 months without 
intervention. Additionally, Boesch et al. (2005) also demonstrated sustained 
improvements in sub-maximal exercise capacity following a one month residential 
CR programme. Both peak watts and exercise duration remained similar to the 
exercise test at end of CR, as well as demonstrating a significantly higher exercise 
capacity compared to baseline levels (p = <0.001).  Furthermore, consistent with the 
current study, Marchionni et al. (2003) also reported that improvements in exercise 
capacity as a result of CR were maintained up to 12 months following discharge in 
patients post MI. This was significantly different to those who did not participate in 
CR. 
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However, unlike the current study which demonstrated that participants maintained 
their level of aerobic fitness two years following completion of CR other studies have 
reported notable declines in exercise capacity following completion of the CR 
programme. Smith et al. (2004) and Stahle et al. (1999) observed considerable 
declines in exercise capacity to almost baseline levels, between the period from the 
end of the CR programme to follow-up at 12 months. Evidence has demonstrated 
that just 30 to 60% of those who complete an outpatient CR programme are still 
physically active between three to six months later (Holmback, Sawe & Fager, 1994; 
Moore et al., 1998). Possible reasons to explain this contrast compared to findings 
in the current study may lie in differences in the levels of habitual physical activity in 
study participants. The significant decline in exercise capacity in a study by Smith et 
al. (2004), reported that those who were in the ‘hospital exercise’ group 
demonstrated substantial declines in the levels of habitual independent physical 
activity compared to the ‘home exercise group’. This resulted in those who had been 
in the ‘hospital CR’ group having a lower exercise capacity at the one-year follow-
up.   
In the current study, the majority of participants were performing more than 
approximately 3,000 total MET-minutes per week (Table 18) which is enough to 
produce substantial health benefits (Meusel, 2008). Independent physical activity 
prior to finishing CR was not measured, therefore comparisons of any change in 
habitual physical activity independent from CR was not possible. Furthermore, the 
majority of participants in the current study (58%) participated in moderate intensity 
activities, classified using the IPAQ. Given that participants in the current study 
maintained their aerobic fitness two years after completion of CR it is perhaps 
surprising that no significant relationship was observed between the volume of 
independent physical activity and aerobic capacity (p=>0.05). Therefore the null 
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hypothesis could not be rejected. There is no significant relationship between the 
volume of physical activity (measured in MET-minutes per week) and aerobic fitness 
(estimated peak METs at two years). It must be noted that the IPAQ is a subjective 
tool used to assess physical activity levels so it is possible that some participants 
may have interpreted their physical activities at a higher intensity and/or on a more 
frequent basis than may have actually been the case. Following the end of CR, 
participants in the current study were advised and encouraged to maintain and 
improve on their future level independent physical activity/exercise levels through 
walking, cycling etc. In some cases, if available, participants were also offered the 
option of undertaking phase IV CR exercise at a local leisure centre if they so 
wished. In the current study it was apparent that a number of participants had 
independently continued to exercise at a gym based facility and/or at home following 
completion of CR, this is likely to have had a notable bearing on the results and is 
likely to have helped them to maintain their aerobic fitness at the two year follow-up.  
A possible mechanism for the maintenance in aerobic capacity at two years after 
completion of CR, was that an element of self-monitored hospital-based CR (i.e. 
patients monitoring their own heart rate and RPE and self-pacing during exercise) 
may have helped foster greater independence when it came to leaving the CR 
programme and exercising independently, without supervision. The CR programme 
at the hospital where the current study took place, tried to foster self-management of 
the exercise programme in the early stages of CR and perhaps it is this that helps 
stimulate a more permanent lifestyle change which has long-term benefits to 
participants’ aerobic fitness. Further evaluation of this is warranted to understand 
what can best motivate patients to continue to maintain exercise/physical activity 
independently following a cardiac event.    
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Another reason for the maintenance in aerobic capacity after two years following 
completion of the CR programme in the current study is that it is possible that those 
participants who agreed to attend for the study (at the two year point) may have 
been more motivated to make and sustain positive health behaviours following their 
cardiac event, since volunteers are more likely to adhere to an exercise regime due 
to their expressed desire to participate (Daltroy, 1994). It could be speculated, that 
perhaps those who chose not to participate in the study were less physically active, 
had not maintained their previously more positive health behaviours and did not 
want to know what they might have been already aware of with regards to their 
health. A reason for individuals with a cardiac history not participating in the study, 
their level of aerobic fitness and volume of habitual physical activity, is an area 
which requires further examination in order for these individuals to also gain long-
term improvements in aerobic fitness and cardiovascular health.   
 
An important and encouraging finding in the current study was that participants 
demonstrated approximately a 0.9 MET improvement overall in aerobic capacity 
(Table 3) between testing at baseline (prior to starting CR exercise) and at the two 
year follow-up.  A higher level of aerobic fitness even in the presence of other risk 
factors such as hypertension, diabetes and smoking, provides a protective role to 
the individual, since every one MET increase in performance is associated with a 12 
percent improvement in survival (Myers et al., 2002).  
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4.3 Secondary measures relating to Cardiovascular Health Profile  
 
The study demonstrates that a number of benefits of CR are sustained at two years, 
although this is to an extent attenuated compared with the level of improvement 
attained at the end of CR (completion of the CR programme). When compared with 
levels at the start of CR; total blood cholesterol and HADS score (both anxiety and 
depression subscales) demonstrated improvements at two years.  
 
The current study found that there was no significant difference in body 
anthropometrics (body weight and abdominal waist circumference) between the 
three time points: baseline, end of CR and at two years (p>0.05). Therefore the null 
hypotheses cannot be rejected. There is no significant difference between waist 
circumference at the end of CR and at the two year follow-up, and there is no 
significant difference between body weight at the end of CR and body weight at the 
two year follow-up. Following completion of the CR programme there was a minimal 
non-significant reduction in waist circumference by approximately 0.8cm at the end 
of CR.  However, after two years after completion of CR abdominal waist 
circumference increased by approximately 3 centimetres since the end of CR, this 
was not statistically significant (p>0.05, Table 10).  Changes in waist circumference 
relate closely to intra-abdominal fat mass (Pouliot et al., 1994) and changes in waist 
circumference reflect changes in cardiovascular risk factors (Wing & Jefferey, 1995). 
Waist circumference cut-off’s have been proposed by Lean et al. (1995) as > 102cm 
in men, > 88cm in women. These cut-offs have been endorsed by consensus 
conferences on obesity and the metabolic syndrome (National Institutes of Health, 
1998; Expert panel on detection, evaluation, and treatment of high blood cholesterol 
in adults [Adult Treatment Panel III], 2001). Clinically the mean 3cm increase in 
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waist circumference observed in participants between the end of CR to two years 
was significant, waist circumference rose from 99.5 to 102.5cm at the two year 
follow-up. In the current study at the two year follow-up participant’s had an 
increased risk of developing more cardiovascular risk factors and/or further 
progression of already established risk factors (such as elevated total cholesterol, 
insulin resistance syndrome and insulin dependent diabetes mellitus).  
The study participants’ body weight increased from the end of CR to the two year 
follow-up by 0.8 kilograms, again this was not statistically significant. Both waist 
circumference and body weight values were found to be higher at the two year 
follow-up than they were at baseline levels. The findings from the current study were 
consistent with previous findings, Willich et al. (2001) suggests that body weight and 
serum lipid (cholesterol) levels increase as early as six months after CR has 
finished, Gupta et al. (2007) also reported small but statistically non-significant 
increases in body weight (measured by body mass index) at one year follow-up 
compared to baseline. Following completion of CR it is possible that without the 
weekly face-to-face contact provided by the multi-disciplinary CR team during the 
programme, participants were slightly less strict in terms of eating the same portion 
sizes and exercising to the same extent. This may have had some impact on the 
participants’ follow-up body weight and also waist circumference two years following 
CR completion.  
 
Total cholesterol was recorded at three time points: baseline, at the end of CR and 
at two years following CR. The results (Table 11) demonstrated no significant 
difference between cholesterol levels either time point, with a small but non-
significant increase in total cholesterol from 4.0 (+ 0.2) mmol/l at the end of CR to 
4.1 (+ 0.2) mmol/l two years following CR completion. Therefore the null hypothesis 
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cannot be rejected. There is no significant difference in total cholesterol at the end of 
the CR programme and total cholesterol at the two year follow-up. Encouragingly, in 
the current study, the participants’ total cholesterol levels collectively, remained 
slightly below baseline levels, with a 0.3 mmol/l mean reduction in total cholesterol. 
This overall reduction could have a considerable positive impact on CHD related 
mortality since it has been reported that a 0.4 mmol/l decrease in total cholesterol 
can reduce CHD deaths by approximately 25% (Prospective Studies Collaboration, 
2008).  Gupta et al. (2007) reported that total cholesterol levels were largely 
maintained at follow-up (one year following CR completion) with no significant 
change observed, although, consistent with the current study, a slight increase was 
seen. However, unlike the present study, at the follow-up, total cholesterol levels 
were significantly lower than baseline levels. In contrast, Boesch et al. (2005) 
observed a significant increase in total cholesterol at the two year follow-up 
compared to levels at the end of CR, this was likely due to the careful control of diet 
and lifestyle whilst the participants resided at the CR centre, which perhaps was not 
sustainable long-term. However, participation in CR has generally resulted in small 
but statistically significant improvements in blood lipids (Lavie & Milani, 2000).  
 
It is recommended that in individuals diagnosed with CHD, total cholesterol should 
fall below 4 mmol/l (NICE, 2008). In the current study the mean total cholesterol was 
4.1 (+0.2) mmol/l, inadequate cholesterol control was observed in 54.2% of the 
study’s participants who were noted to have a total cholesterol of greater than 4 
mmol/l at the two year follow-up. This is consistent with other studies that have 
observed that approximately 50% of patients with coronary artery disease were not 
appropriately controlled for elevated plasma cholesterol (EUROSPIRE study group, 
1997).  It is plausible that reasons for the differences in total cholesterol between the 
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current study’s participants were due to differences in pharmacological treatment 
and/or the adherence of the participant to their medication regime. One of the aims 
of CR is to reduce the risk of short and long-term mortality from coronary artery 
disease and therefore appropriate long-term management of individuals’ weight and 
abdominal waist circumference is of great importance, by both the individual 
themselves and appropriate health professionals (e.g. general practitioner, CHD 
nurse etc). This is an area of secondary prevention which requires further attention  
in order to reduce potential risk of future hospital readmissions and earlier CHD 
related mortality and morbidity. 
 
There was no significant difference in participants’ RPP (a clinical measure of 
myocardial oxygen demand) at any time point (baseline to two year follow-up). 
There was no significant difference between the participants RPP at the end of CR 
and RPP at the two year follow-up and therefore the null hypothesis (5) could not be 
rejected.  A small, non-significant rise in RPP was observed at the two year follow-
up compared to at the end of CR despite the lower mean systolic blood pressure at 
the two year follow-up. This increase in RPP was due to higher overall mean heart 
rates achieved by the participants at 75% HRmax at the two year follow-up test which 
was on average within 1bpm higher at the two year follow-up compared to the 
exercise test at the end of CR (mean 106 + 10.1 bpm at the end of CR vs. 107 + 
10.7 bpm at two years). This suggests that participants in the current study on 
tended to work at a harder level on average overall, which was reflected in an 
increase in myocardial oxygen consumption through a higher RPP at the two year 
follow-up. Typically, after regular aerobic training patients experience a reduction in 
RPP which is largely due to reduction in sub-maximal heart rate and blood pressure. 
This leads to reduction in myocardial oxygen consumption at sub-maximal 
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workloads because of a lower myocardial oxygen demand at sub-maximal 
workloads (Thompson, 2005). 
 
HADS scores were measured at baseline, the end of CR and at the two year follow-
up. The important finding with regards to quality of life measures through use of 
HADS was that at the two year follow-up, both the anxiety subscale (HADS-A) and 
depression subscale (HADS-D) were reduced from baseline levels (Table 16).  This 
may suggest that the CR programme positively influenced participants’ overall   
quality of life through reductions in overall anxiety and depression levels. A 
statistically significant reduction was observed between the HAD-D at the end of CR 
compared to baseline (p<0.017), and this lower depression score was maintained at 
the two year follow-up (Table 16). No significant difference was observed between 
participants’ anxiety specific and depression specific scores between the end of CR 
and the two year follow-up (p>0.017). Therefore, the null hypothesis could not be 
rejected. There was no significant difference between HADS scores at the end of the 
CR programme and the HADS score at the two year follow-up. HADS scores (for 
anxiety subscales and depression subscales)  of 0-7 are clinically within the ‘normal’ 
range, with scores of 8-10 indicating ‘mild’ cases, scores of 11-15 ‘moderate cases’ 
and greater than 16 ‘severe cases’ (Snaith & Zigmond, 1994).  Interestingly, in the 
current study the median scores from baseline through to two year follow-up were all 
clinically non-significant with scores for both anxiety and depression subscales 
remaining on average, within the clinically ‘normal’ range.  
Although not the main focus of the study, whether the overall ‘normal’ HADS score is 
typical of the wider CR population requires further investigation. Although the mean 
HADS-A and HADS-D scores were not presented in the results due to the non-
65 
 
normal distribution of statistical data, the mean scores perhaps offer a better clinical 
clarification of the overall change in HADS scores at each time point. HADS-A was 
5.4 (+4.4) at baseline, 4.1 (+4.4) at the end of CR, and 3.7 (+3.3) at the two year 
follow-up. HADS-D:  3.3 (+4.0) at baseline, 1.7 (+2.8) at the end of CR, and 2.4 
(+2.7) at the two year follow-up.  
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4.4 Limitations of the study 
This study was limited by the absence of a control group. It is possible that those 
participants who attended the CR programme and agreed to return for this research 
study were particularly motivated to make health and lifestyle changes such following 
their respective cardiac event. Reason’s for participant’s not responding to mailings 
during the follow-up period and subsequently not returning for the two year follow-up 
was not available. This could have potentially biased the results, furthermore, it is 
likely that patients who returned for follow-up differ in a number of characteristics 
compared to those who chose not to; further research is required to ascertain if this 
is the case. It is also possible that the cardiac event itself may have influenced 
health-related behaviours without participating in a CR programme. Of note, 62.5% 
of the study’s participants were retired, and therefore, may have had more time 
available to engage in leisure and recreational activities following their cardiac event. 
Finally, the generalisability and interpretation of the current study’s findings require 
some caution due to the small sample size used. Furthermore, the study sample 
consisted exclusively of Caucasian individuals, the majority of which were male 
(79%). This represents a national trend of CR programmes in the UK, whereby 
women are typically less likely to be referred or join a CR programme (Rees et al., 
2005; British Heart Foundation, 2009b).   
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4.5 Conclusion 
After two years following a cardiac event and participation in a structured twelve 
week CR programme that included exercise and health education, patients 
maintained their aerobic fitness and improved aspects of their cardiovascular health 
profile. These findings suggest that CR can act as a catalyst to help motivate, guide 
and support individuals following a cardiac event to adopt and maintain positive 
health behaviours, maintain their aerobic fitness and reduce their long-term 
cardiovascular risk. This is still evident two years after completion of CR. Further 
secondary prevention research is needed to guide interventions for long-term health 
benefits that will address not only the needs of Caucasian males, but females and 
other individuals from different ethnic backgrounds in order to improve patients’ long-
term well-being.  
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APPENDIX 1: TABLE TO SUMMARISE COMPARABLE STUDIES EXAMINING EXERCISE CAPACITY & TYPICAL FOLLOW‐UP PERIOD   
Author  Study Design  Sample  Methods  Measures used  Main findings  Typical follow‐up 
Boesch et 
al.(2005) 
Repeated 
Measures  
78  CR patients 
(post MI, 
CABG, PCI)  
• 1 month residential 
programme 
• 5x  30 mins per week 
indoor cycling sessions 
•  2 daily 45 mins walk, 
• subjects divided into 3 
training groups 
• Maximal 
exercise test 
at baseline, 
post rehab, at 
2 years 
• Physical 
Activity 
Questionnair
e 
• Blood Lipid 
testing 
• At 2 years exercise 
capacity was 
maintained 
• At 2 years, peak 
workload (watts) 
remained significantly 
higher compared to 
baseline. 
Two years 
Smith, 
Arthur, 
McKelvie & 
Kodis 
(2004) 
Repeated 
Measures 
222 CABG 
patients 
• Six months hospital 
vs. monitored home-
based CR 
• Patients advised to 
exercise 5 x per 
week after CR 
discharge 
• Maximal 
exercise test 
at baseline 
and 12 
months 
• Habitual 
physical 
activity  
• HRQoL (SF‐
36) 
• Anthropomet
rics  
• Social support
• At follow‐up peak VO2 
declined in hospital 
group 
• Home group 
maintained peak VO2 
• Both groups maintained 
higher peak VO2 vs. 
baseline  
One year 
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Stalhe et al. 
(1999) 
Repeated 
Measures 
101 patients 
post acute 
coronary 
event aged 
>65 yrs  
• Randomised into 2 
groups: Intervention (I) 
& control (C) 
• (I) 50 min aerobic 
outpatient exercise 
programme ,  
3 x p/w for 3 months 
• (C) resume usual 
physical activity when 
able 
• Maximal 
exercise 
capacity at 
baseline, 3 & 
12 months 
• HRQoL 
• Self‐graded 
level of 
physical 
activity & 
well‐being 
• (I) Increased Exs. 
Capacity at 3 months 
but this declined to 
near baseline at one 
year 
• Exs. Capacity 
significantly higher than 
baseline at 1 year 
follow‐up 
• One year 
Arrigo et al. 
(2008) 
Repeated 
Measures 
261 patients 
enrolled 
following 4‐
week inpatient 
or 12 week 
outpatient CR 
programme 
• Two groups 
(intervention‐INT and 
control‐ UC) 
• Physician supervised 3 
monthly exercise 
sessions & keep a 
physical activity diary 
• UC‐no instruction, only 
return at 1 year. 
• Exercise test 
at baseline 
and 1 year 
• Physical 
activity 
• Risk factors 
• HRQoL 
• Significant 
improvement in 
exercise capacity at 
follow‐up in both 
groups  
• More patients in INT 
group adhered to 
regular physical activity  
One year 
Marchionni 
et al. (2003) 
Repeated 
Measures 
270 patients 
post MI 
• Randomised into 3 
groups: hospital CR, 
home CR or no CR 
• Divided into 3 aged 
groups 45‐65, 66‐75, 
>75 years. 2 month 
period. 
• Total work 
capacity 
(TWC) in 
watts at 
baseline, 6 
months and 
12 months 
• Improvement in TWC in 
each age group with 
Hosp‐CR and Home‐CR, 
unchanged with no CR. 
• TWC declined to almost 
baseline by 12 months 
in Hosp‐CR but not 
Home‐CR 
• One year 
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Appendix 2 
Version 1. 01/03/2011 
Dear Sir/Madam  
Re: Title of Project: Aerobic Fitness and Cardiovascular Health Profile Two Years 
after Completion of Cardiac Rehabilitation, REC Ref: 11/WM/0072 
Principal Researcher: Steve Padmore, Exercise Physiologist in Cardiac 
Rehabilitation (Good Hope Hospital – Heart of England NHS Trust) 
 
I would like to ask for your assistance with a research study that I am conducting as 
part of my Master of Science (MSc) degree in Cardiovascular Rehabilitation. The 
study aims to investigate whether a cardiac rehabilitation programme can be 
effective in maintaining aerobic fitness. Please read the information sheet enclosed 
for more details. 
 
Please read the enclosed information sheet carefully before deciding whether or not 
to participate. If you decide to participate we thank you.  If you decide not to take part 
there will be no disadvantage to you of any kind and I thank you for considering our 
request.   
 
Once you have read the information sheet if you are interested in taking part in the 
research or finding out more about it, I would be grateful if you would contact me, 
Steve Padmore on the number below within fourteen days of receiving this 
letter.  
Cardiac Rehabilitation Department (Good Hope Hospital): - Tel: 0121 424 7465     
Yours Sincerely  
Steve Padmore – Exercise Physiologist-Cardiac Rehabilitation 
Student Researcher 
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Appendix 5   10.04.2011. Version 2 
CONSENT FORM FOR PARTICIPANTS 
Title of Project: Aerobic Fitness and Cardiovascular Health Profile Two Years after Completion of 
Cardiac Rehabilitation 
Please tick each box to confirm you agreement  
• I confirm I have read and understood the Participant Information Sheet concerning the 
above study.  
 
•  I have had the opportunity to consider the information and ask questions all of which 
have been answered to my satisfaction.  I understand that I am free to request further 
information at any stage. 
 
• I consent to the researcher informing my GP of my participation in this study. 
 
• My participation in the study is entirely voluntary and I am free to withdraw from the 
study at any time, up until the project is submitted, without any   reason and without 
my medical care or legal rights being affected.                
 
• The information I provide and all data collected from the study, in accordance with 
the Data protection Act 1998, will be treated as confidential and anonymous. 
 
• I agree that Steve Padmore can access my medical information for consultant letters, 
previous blood results, results concerning my cardiac investigations (e.g. 
echocardiogram results), and demographic information (your GP address, home 
address and date of birth). All this information will be used to confirm your identity 
for the purpose of the study and to ensure appropriate action can be taken if anything 
demands further medical assistance or investigation.  
 
• I agree to undertake an exercise assessment as part of study which will involve (1) a 
full health screen covering my cardiac and medical history, medication, joint/muscular 
problems and current physical activity/exercise. (2) I agree to participate in an 
exercise test on a stationary exercise bike while having my heart rhythm, blood 
pressure, and Rating of Perceived Exertion monitored by the researcher, Steve 
Padmore.  
 
• Parts of the data collected during the study may be examined by the research 
supervisors of Steve Padmore or regulatory authorities and I give permission for this. 
 
• In keeping with University of Chester policy any data or results on which the project 
depend will be retained in secure storage for ten years, after which it will be 
destroyed; the results of the study for this MSc Dissertation may be published on the 
ChesterRep, which is the University of Chester's online repository but my anonymity 
will be preserved. I agree to this. 
• I understand that I will receive a written summary of the findings of the study. 
 
I therefore give my consent to take part in this research study. Please sign and date: 
...................................................................  …………      ................................... 
Participant Name                                          Date               Signature   
…………………………………………..   …………     ……………………… 
Name of researcher taking consent          Date               Signature  
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Version 2. 10/04/2011 
PARTICIPANT INFORMATION SHEET  
Title of Project: Aerobic Fitness and Cardiovascular Health Profile Two Years after Completion of Cardiac 
Rehabilitation 
Principal Researcher: Steve Padmore, Exercise Physiologist in Cardiac Rehabilitation 
I would like to ask for your assistance with a research study that I am conducting as part of my 
Master of Science (MSc) degree in Cardiovascular Rehabilitation. The study aims to investigate 
whether a cardiac rehabilitation programme can be effective in maintaining aerobic fitness. Please 
read this information sheet carefully before deciding whether or not to participate. If you decide to 
participate we thank you.  If you decide not to take part there will be no disadvantage to you of any 
kind and I thank you for considering our request.   
 
Why have I been invited to take part? 
Because you have previously completed the Cardiac Rehabilitation programme. 
 
How many others will be in the study? 
You will be among at least 25 other people who will also participate in the study.  
 
What is the purpose of the study? 
The purpose of the study is in part educational and in part service evaluation: the project will be 
submitted as part of an MSc in Cardiovascular Rehabilitation at the University of Chester. The main 
purpose of the study is to determine if a standard cardiac rehabilitation programme (lasting three 
months) can be effective in maintaining aerobic fitness two years after completion of the 
programme. Though this is standard it is a relatively short period. The secondary aims of the study 
are (1) to examine changes in the participants' cardiovascular health profile two years after 
completing cardiac rehabilitation (blood cholesterol, resting blood pressure, smoking status, body 
weight, waist circumference) (2) The study will also investigate changes in Hospital Anxiety and 
Depression scores, examine current physical activity levels, quality of life status and the number of 
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hospital re‐admissions (cardiac and non‐cardiac related causes) since finishing the rehabilitation 
programme. 
 
Do I have to take part? 
Your involvement in this study is voluntary. Your decision will not affect your medical care or 
disadvantage you in any way.  
 
What will I be asked to do? 
Should you agree to take part in this study, you will be asked to complete three short 
questionnaires. These questionnaires assess your current physical activity levels, mood and your 
quality of life. You will also be invited to the hospital’s cardiac rehabilitation department to perform 
an exercise assessment which consists of a full health screen and a static bike ride which will last 
about six to eight minutes while having your blood pressure, heart rate/rhythm and your Rating of 
Perceived Exertion assessed. This is exactly the same test you performed previously approximately 
two years ago. The appointment for the exercise assessment will last approximately 60 minutes in 
total.  Should anything untoward be noted on the heart monitor (i.e. ECG machine) during the 
assessment you will be advised to be referred via your GP back to a consultant cardiologist for a 
clinical review. 
 
What are the benefits of taking part? 
Participating in this study may help evaluate your cardiovascular health, how fit you are and what 
type of physical activity/exercise is suitable for you. Your participation in this study may help to 
identify aspects of cardiac rehabilitation which require greater focus or change, helping to improve 
the benefits of rehabilitation for future patients. 
 
What are the risks of taking part? 
The risks are no different to what you previously experienced when attending the cardiac 
rehabilitation programme. We will carry out another health‐screen to identify any changes since we 
last saw you. The researcher is an experienced Exercise Physiologist within the Cardiac Rehabilitation 
Team at Good Hope Hospital who has training and competence in exercise testing.  Although a sub‐
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maximal exercise assessment may be considered a safe procedure, risks and complications may 
occasionally arise during the test. These include abnormal blood pressure, fainting, irregular, fast or 
slow heart rhythms and rarely, heart attack, stroke or death, however, you will be continually 
monitored throughout to minimise any potential problems to yourself. 
 
Will Medical Staff know I am involved in the study? 
Yes. Both a Dr Richard Watkin (Consultant Cardiologist) and Harry Dranginis (Cardiac Rehabilitation 
Nurse Co‐ordinator) based at Good Hope Hospital are aware of the study and your eligibility to take 
part.  
 
Can Participants Change their Mind and Withdraw from the Project? 
Yes. You may withdraw from the study at any time up until the point where the research project has 
been submitted, without giving a reason and without it affecting your medical care. This can be 
done through contacting me or Dr John Buckley. 
 
Will my participation in the study and data be kept confidential? 
Yes, we will follow ethical and legal practice and all information about you will be handled in 
confidence in accordance with the Data protection Act 1998. For the purpose of the research your 
medical information will be accessed by only me (the researcher). All information collected about 
you during the course of the research will be kept strictly confidential and anonymous.  
 
Who is organising/funding the research? 
The research is in partnership the University of Chester and with the permission of the Heart of 
England NHS Foundation Trust. This research is supported and supervised by Dr John Buckley, BASES 
Accredited Sports and Exercise Scientist, University of Chester.  
 
Who has reviewed the study? 
94 
 
All research in the NHS is examined by an independent group of people called a Research Ethics 
Committee (REC) to ensure your safety, rights, dignity and wellbeing. The study has been approved  
 
by the Birmingham East North & Solihull REC and the hospital Trust’s Research and Development 
department. 
 
What if I have any questions or concerns? 
If you have any questions or would like further information about any aspect of the study or 
regarding participating, please contact the researchers using the contact details below. If at any 
point you remain unhappy and wish to make a formal complaint, you can do so through the 
University of Chester complaints procedure, details of which can be obtained from the University.  
You should contact me, the principal researcher, in the first instance. 
 
What do I do now? 
If you are interested in taking part in the research or finding out more about it, I would be grateful if 
you would contact me, Steve Padmore on the number below within fourteen days of receiving this 
information sheet. I will then send you some short questionnaires to complete and organise an 
appointment for the exercise assessment. If you have any further questions about the study please 
do not hesitate to contact me. Contacting me about the study does not mean you are obliged to 
take part.  
 
Researcher contact details: 
Principal Researcher: 
Steve Padmore 
Exercise Physiologist  
Cardiac Rehabilitation 
Good Hope Hospital 
Cardiac Rehabilitation Department Telephone Number: ‐ [0121 424 7465]      
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Academic Supervisor   
Dr John Buckley 
University of Chester        
Department of Clinical Sciences 
Parkgate Road 
Chester 
CH1 4BJ 
University Telephone Number: ‐ [01244 511 692]   
It may not be possible for us to take your call immediately but please give us details of how we may 
contact you and we will return your call as soon as possible.  
 
Patient Advice and Liaison Service (PALS): 
Office Address 
Patient Advice & Liaison Service 
Office Telephone Number: ‐ [0121 255 0707]   
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Version 1. 01.03.2011 
Pre-exercise assessment Health screening form 
Participant number/code:   Participant age: 
Date: 
 
Current medication: 
Name Dose 
  
  
  
  
  
  
  
  
Current physical activity/exercise:  
 
Is the participant a smoker (please circle): Yes / No 
 
 
Chest Pain 
(Including recent use of 
GTN spray) 
 
 
 
Breathlessness   
Palpitations  
Dizziness/Fainting/Blackouts  
Orthopnoea  
Ankle swelling  
Claudication  
Wound problems  
Musculoskeletal 
limitations/problems 
 
Ex-smoker (please circle):  Yes/ No - If yes, how long have they not 
smoked? 
 
 Appendix 6 
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Pre – Exercise Test Checklist 
Medical consent gain  
 
Participant gives informed consent 
 
 
 
BP controlled (SBP <180) (DBP <100) 
 
 
Client taken all prescribed medication 
 
 
Client free from cold, sore throat or other temporary 
illness 
 
 
Client no on antibiotics 
 
 
No other hospital admissions in the past 4 weeks which 
indicate unstable cardiac status  
 
 
No musculoskeltal problems that could be exacerbated 
by the exercise test 
 
 
If the participant is diabetic, no hypoglycaemic episodes 
in the past seven days 
 
 
No acute signs of heart failure 
 
 
No excessive alcohol consumption in the past 24 hours 
 
 
No caffeine consumption in the past two hours 
 
 
No heavy meal in the past two hours 
 
 
No strenuous physical activity 24 hours prior to the test 
 
 
Client is wearing suitable clothing/footwear. 
 
 
 
Access to telephone and cardiologist/Cardiology Doctor 
in emergency 
 
 
 
Resuscitation equipment accessible and checked 
 
 
 
Tester competent in basic/immediate life support 
 
 
 
Flow Chart of Recruitment and Data Collection Procedure 
Appendix 7 
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2. Participant information sheets and participant informed consent form posted out by the student 
researcher (Appendix) to participants meeting the inclusion criteria 
1. Potential participant identified from the Cardiac Rehabilitation database from 2008‐2009 who 
meets the study inclusion criteria 
3. Participant contacts researcher via telephone to discuss aspects of the study in further detail 
and potential participation in the study is decided upon 
No further contact from the 
researcher 
Individual does not agree to 
participate 
 
4. Individual agrees verbally to 
participate in the study 
6. IPAQ (short version), SF‐12 
& HADS questionnaires posted 
to participant. Date and time 
arranged for hospital exercise 
cycle assessment 
5. Participant completes and 
returns informed consent form 
via pre‐paid envelope 
9. Participant fulfils the criteria to for 
exercise and performs the exercise cycle 
test.  Verbal informed consent is gained 
before beginning and participant 
performs the exercise test, lasting about 
6‐ 8 minutes 
8. Researcher carries out pre‐
exercise screening  
7. Participant attends hospital 
to for exercise assessment and 
returns questionnaires to 
researcher 
Participant is deemed 
unsuitable to perform the 
exercise test  
Participant does not take part 
in exercise test and as 
appropriate is: re‐booked to 
return to do the test on 
another date, is referred to 
their respective GP, or is 
discussed with the cardiologist 
Participant is deemed 
unsuitable to perform the 
exercise test  
10. At the end of the exercise assessment the participant will be informed that they may contact the researcher if 
they have any further questions or concerns and they are handed a debriefing sheet.  
A 
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Version 2. 10.04.2011 
PARTICIPANT DEBRIEFING SHEET  
Title of Project: Aerobic Fitness and Cardiovascular Health Profile Two Years After 
Completion of Cardiac Rehabilitation 
Principal Researcher: Steve Padmore, Exercise Physiologist in Cardiac Rehabilitation 
Thank you for taking part in the above study. You may find the following information 
useful. 
 
What is the purpose of the study? 
The purpose of the study is in part educational: the project will be submitted as part of a 
research project for a Master of Science degree in Cardiovascular Rehabilitation at the 
University of Chester. The main purpose of the study is to determine if a short-term cardiac 
rehabilitation programme (lasting three months) can be effective in maintaining aerobic 
fitness two years following completion of a hospital-based cardiac rehabilitation programme. 
The secondary aims of the study are (1) to examine changes in the participants' 
cardiovascular health profile two after completing cardiac rehabilitation (blood cholesterol, 
resting blood pressure, smoking status, body weight, waist circumference) (2) The study will 
also investigate changes in Hospital Anxiety and Depression scores examine current 
physical activity levels, quality of life status and the number of hospital re-admissions 
(cardiac and non-cardiac related causes) since finishing the rehabilitation programme. 
 
What if I wish to withdraw from the study? 
You may withdraw from the study at any time up until the point the research project has 
been submitted, without giving a reason and without it affecting your medical care. This can 
be done through contacting me or Dr John Buckley. In this instance any personal data 
collected as part of the study will be removed and destroyed. 
 
Will my participation in the study and data be kept confidential? 
Appendix 9 
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Yes, we will follow ethical and legal practice and all information about you will be handled in 
confidence in accordance with the Data protection Act 1998. For the purpose of the research 
your medical information will be accessed by only me (the researcher). All information 
collected about you during the course of the research will be kept strictly confidential and 
anonymous. Some aspects of this data may be accessed by authorised individuals from the 
University of Chester or representatives from regulatory authorities to check the study is 
being correctly carried out. These individuals all have a duty of confidentiality to you as a 
research participant. Your data will be stored in a confidential locked cabinet within the 
Cardiac Rehabilitation Department during the study; this will only be accessed by me. When 
the study is complete, all of your personal information will be destroyed immediately except 
any data on which the results of the project depend: this will remain anonymous and be 
retained in secure storage for ten years, as required by the University's research policy. 
 
Who is organising/funding the research? 
The research is in partnership the University of Chester and with the permission of the Heart 
of England NHS Foundation Trust. This research is supported and supervised by Dr John 
Buckley, BASES Accredited Sports and Exercise Scientist, University of Chester.  
 
What will happen to the results of the study? 
After participating in the study you will receive no further contact from the researcher with 
regards to the study. Although a summary of the findings will be sent to you: if you do not 
wish to receive this information please contact Steve Padmore. Your future medical care will 
not be affected  
 
Contact Information 
If you have any questions or concerns regarding this study or you feel you need to speak to 
a professional concerning anything raised by the research, you may contact Steve Padmore, 
the principal researcher.  If at any point you remain unhappy and wish to make a formal 
complaint, you can do so through the University of Chester complaints procedure, details of 
which can be obtained from the University.  The Cardiac Rehabilitation Coordinator is aware 
the research is taking place but is separate to the research team and can be contacted if 
needed. Participation in the study is separate to the medical care you receive, for queries 
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regarding your medical care please see your GP or medical professional involved in your 
care. 
 
Contact details: 
Principal Researcher: 
Steve Padmore 
Exercise Physiologist  
Cardiac Rehabilitation 
Good Hope Hospital 
Cardiac Rehabilitation Department Telephone Number: - [0121 424 7465]      
 
Academic Supervisor  
Dr John Buckley 
University of Chester       
Department of Clinical Sciences 
Parkgate Road 
Chester 
CH1 4BJ 
University Telephone Number: - [01244 511 692]                                                                                             
For Further Support 
British Heart Foundation (BHF) Heart Support Groups - To find your nearest support group call the 
HeartHelpLine  on 0300 330 3311 (local rate number) or email: supporterservices@bhf.org.uk.  
A heart support group offers the chance for patients to share their experiences in a friendly and 
mutually supportive environment and provides a range of benefits and activities for their members. 
Patient Advice and Liaison Service (PALS): 
Office Address 
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Patient Advice & Liaison Service 
Office Telephone Number: - [0121 255 0707]   
 
 
Appendix 10: PASW outputs for statistical analysis on study participants 
 
Output to interpret normal distribution of aerobic capacity measured by watts 
achieved at 75% HRmax at each assessment: CR baseline, End of CR and at two 
years after CR  
 
 
Assessment of sphericity for peak watts data 
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Output to interpret normal distribution of the Aerobic Fitness (measured by 
METs achieved at 75% HRmax) for the different assessment time points (CR 
baseline, End of CR and at two year post completion CR). 
 
 
Test for normality of Rate Pressure Product (RPP) values at est.75% HRmax 
baseline, discharge and two year follow-up.  
 
 
 
Test of Sphericity for RPP data 
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Results of One-way (repeated measures) ANOVA to test for differences in pre-
exercise SBP 
 
 
 
 
Test of normal distribution of data for participants’ diastolic blood pressure (DBP) at 
three time points (baseline, end of CR and at two years) 
Tests of Normality 
 Kolmogorov-Smirnov
a Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Pre exercise Diastolic BP (mmHg) .146 24 .200* .938 24 .146
Pre exercise Diastolic BP (mmHg) .127 24 .200* .947 24 .238
Pre exercise Diastolic BP (mmHg) .083 24 .200* .979 24 .883
a. Lilliefors Significance Correction 
*. This is a lower bound of the true significance. 
 
 
Results of test for sphericity of pre-exercise DBP data 
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Results of One-way (repeated measures) ANOVA to test for differences in pre-
exercise DBP 
 
Interpretation of normality for Hospital Anxiety and Depression Scale (HADS) 
score questionnaire data at baseline, CR discharge and two year follow-up 
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Test for normality of data of Total physical activity MET-minutes per week and 
peak METs at the two year follow-up 
 
 
 
Test of normality for two year follow-up waist circumference and total 
cholesterol data 
Tests of Normality 
 Kolmogorov-Smirnov
a Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
waist circumference @ 2 year 
follow-up (cm) 
.098 23 .200* .940 23 .179
total blood cholesterol (mmol/l)@ 2 
years 
.103 23 .200* .968 23 .644
a. Lilliefors Significance Correction 
*. This is a lower bound of the true significance. 
 
 
 
 
 
 
 
 
112 
 
Appendix 11 – Raw Data 
 
 
 
 
 
 
Partcipant No. Cardiac condition/diagnosis Age (years) peak METs peak METs peak METs HR  @ peak HR  @ peak HR  @ peak RPE @ peak RPE @ peak RPE @ peak peak watts1 peak watts2 peak watts3
1 STEMI & P.PCI 56 3.5 5.2 3.5 98bpm 114 112 13 12 12 40 84 40
2  F elective PCI to LAD x 2 80 3 3.7 3.5 100 93 103 10 to 11 13 13 25 35 35
3 Ant MI & P.PCI 64 4.3 5.5 5.4 87 100 91 12 to 13 13.5 13 60 84 84
4 Ant MI & thrombolysis 64 n/a 5.5 4.8 133 123 n/a 11.5 15 84 72
5  F TCABG 68 4.5 5.7 5.7 112 111 98bpm 12 11 .5 13 45 72 72
6 NSTEMI 46 n/a 4.6 5 108 114 n/a 13 13 90 90
7 NSTEMI & PCI 70 4.8 5.2 5.6 85 99 88 11 to 12 12 14 78 90 102
8  F Inferior MI & P.PCI 55 4.2 4.6 5 108 106 107 13 14 14 50 60 72
9 Elective PCI  67 4.5 5.1 5.2 86 97 95 13 to 14 12 13 72 90 96
11 QCABG 63 4.3 6.5 5.5 107 96 97 12 13 13 60 120 90
12 NSTEMI 56 3.3 4 4 100 108 122 13 13 13 40 55 55
13  F NSTEMI 63 4 4.3 5 113 101 107 13 13 13.5 50 60 72
14 DCABG & (M) AVR 62 6 6.6 6.1 109 100 113 13 13 14 84 96 96
15 QCABG 70 4.6 5.6 6 103 110 114 13 12 14 60 84 90
16 PCI 81 3.8 4.2 3.7 101 95 106 13 14 14 50 60 50
17 Inferio‐Lateral MI & VF arrest 64 4.5 5.6 5.5 109 112 107 11 13 12 75 100 102
18 Inferior MI & P.PCI 62 4.6 6 5.7 103 109 110 13 13 15 60 90 90
19 PCI 65 3.7 4.8 5.1 91 103 91 11 11 10 50 85 90
20 NSTEMI 65 4.1 4.6 4.8 98 98 102 13 12 15 65 78 84
21 DCABG  79 3.2 3.5 3.4 98 85 97 13 12 15 35 45 40
22 NSTEMI 62 4.5 5.7 5.5 114 109 120 14 14 13 60 90 90
23  F Ant MI & P.PCI 73 3.4 3.7 3.7 122 112 119 14 to 15 11.5 15 25 35 35
24 A‐L MI  54 4.9 4.9 5.2 110 115 106 12 12 13 65 75 84
25 NSTEMI & PCI 62 5 6.1 5.9 105 121 125 13 13 14 102 145 120
Partcipant No. Cardiac condition/diagnosis Age (years) RPP1 RPP2 RPP3 pSBP1 pSBP2 pSBP3 SBP1 DBP1 SBP2 DBP2 SBP3 DBP3 RPP1 RPP2
1 STEMI & P.PCI 56 135 194 164 138 170 146 122 72 139 85 130 83 120 158
2  F elective PCI to LAD x 2 80 110 134 175 110 144 170 125 74 144 88 131 77 125 134
3 Ant MI & P.PCI 64 113 130 122 130 130 134 104 65 104 59 106 65 120 104
4 Ant MI & thrombolysis 64 213 199 160 162 122 88 140 100 130 96 162
5  F TCABG 68 157 162 127 140 146 130 105 70 126 68 97 62 118 140
6 NSTEMI 46 119 114 92 110 110 102 64 100 58 103 67 110
7 NSTEMI & PCI 70 156 196 167 184 198 190 153 74 147 68 146 80 130 146
8  F Inferior MI & P.PCI 55 168 151 161 156 142 150 140 88 154 85 110 71 151 163
9 Elective PCI  67 146 182 165 170 188 174 137 74 112 60 138 78 118 109
11 QCABG 63 201 184 175 188 192 180 168 94 140 84 133 89 180 134
12 NSTEMI 56 134 156 181 134 144 154 105 64 96 56 123 73 105 104
13  F NSTEMI 63 203 168 178 180 166 166 142 86 166 76 136 79 160 168
14 DCABG & (M) AVR 62 198 170 221 182 170 196 143 73 148 68 146 66 156 148
15 QCABG 70 159 200 225 154 182 184 150 81 159 84 156 89 155 175
16 PCI 81 186 144 159 184 152 150 142 64 122 60 149 85 143 97
17 Inferio‐Lateral MI & VF arrest 64 164 199 167 150 178 156 99 67 121 76 114 75 108 136
18 Inferior MI & P.PCI 62 185 194 207 180 178 188 146 83 150 80 146 83 150 164
19 PCI 65 135 165 118 148 160 130 120 80 117 81 116 79 109 121
20 NSTEMI 65 155 157 163 158 160 160 130 64 160 60 116 70 127 157
21 DCABG  79 180 119 149 184 140 154 153 72 143 69 158 74 150 122
22 NSTEMI 62 162 164 180 142 150 150 110 60 109 65 115 68 125 119
23  F Ant MI & P.PCI 73 173 161 179 142 144 150 133 76 133 73 122 79 162 149
24 A‐L MI  54 110 136 136 100 118 128 96 61 115 77 120 75 106 132
25 NSTEMI & PCI 62 202 225 258 192 186 206 141 95 141 84 140 89 148 171
Partcipant No. Cardiac condition/diagnosis Age (years) RPP3 Body Wt (kg) Body Wt (kg) Body Wt (kg) Waist Circ. Waist Circ. Waist Circ. TC (mmol/l) TC (mmol/l) TC (mmol/l) smoker (Yes/no) smoker smoker
1 STEMI & P.PCI 56 146 80.2 84.4 82.2 99 96 3.5 3.5 4.6 no no no
2  F elective PCI to LAD x 2 80 135 66 67.8 70.8 88 87 3.2 4.2 4.7 no no no
3 Ant MI & P.PCI 64 96 80.4 74.4 77 88 90 90 5.1 2.4 no no no
4 Ant MI & thrombolysis 64 172 77.2 77.2 78 89.5 4.7 4.1 3.5 stopped at MI no no
5  F TCABG 68 95 57.4 59.2 61 85 85.5 5.2 4.7 4.9 ex stopped 2yrs ago no no
6 NSTEMI 46 117 106.6 104.6 104.2 116.9 117.5 114.3 5.7 1.8 1.6 ex stopped 2yrs ago no no
7 NSTEMI & PCI 70 128 87.8 86.8 87.8 97.5 100 102.7 4.2 4.8 4.8 ex stopped 40yrs ago no no
8  F Inferior MI & P.PCI 55 118 71.2 68 73.6 88 87 92.3 5.7 5.4 5.6 ex stopped 15yrs no no
9 Elective PCI  67 131 93 92 93.2 103 106.4 107.4 5.3 5.2 5 ex stopped 40yrs ago no no
11 QCABG 63 129 80.8 82.2 82.8 93 98.6 3.5 3.9 4.4 no no no
12 NSTEMI 56 150 95 87.6 86 118 113.2 110.5 4 4.7 5.4 stopped at MI no yes (20/day)
13  F NSTEMI 63 146 78.2 80.2 75.2 97 95 4.7 3.8 3.7 ex stopped 35 yrs no no
14 DCABG & (M) AVR 62 165 66 66.8 70.2 81 81 83.3 2.9 3 no no no
15 QCABG 70 178 70.6 70 70.2 86 85.8 3.6 3.2 3.3 no no no
16 PCI 81 158 85.4 85.2 89 105 110 113.8 4.1 4 4 no no no
17 Inferio‐Lateral MI & VF arrest 64 122 92.8 88.4 93 110 100 115.3 4.1 4.7 4.1 ex stopped 24 years no no
18 Inferior MI & P.PCI 62 161 70.2 71.4 76.8 85 86.4 85 ex stopped 9 yrs no no
19 PCI 65 106 89.6 95.4 88.2 102.5 4.4 4.9 3.6 stopped on admission no yes 
20 NSTEMI 65 118 93 94.8 94.8 112 111 117.2 4.1 3.4 4.1 stopped on admission no yes (2 per month)
21 DCABG  79 153 84 86 89.8 104.1 3.1 2.6 2.6 no no no
22 NSTEMI 62 138 75.4 75.8 79.6 89 89 99 4.4 5 stopped at MI no no
23  F Ant MI & P.PCI 73 145 67.2 66.4 65.6 86 3.4 4.2 5.4 ex stopped 36 yrs ago no no
24 A‐L MI  54 127 72 78.8 83 93 3.5 stopped at MI no no
25 NSTEMI & PCI 62 175 108.2 107.4 98.8 110.5 102.5 102 6.3 3.7 3.1 ex stopped 37 yrs ago no no
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